cbd oil dose for colon cancer

Cbd Oil Dosage For Colon Cancer

How many knots cbd oil for colon cancer cbd oil dosage for colon cancer are there A weeds knot represents one nautical how are cbd gummies legal mile, so it is possible to know how many nautical veterans administration and cbd oil miles the ship has driven during this period of just cbd gummies time, so as to calculate the ship s speed.

As a result, the economic burden is greatly increased. Due to the difficulties of the people, the payment of taxes was naturally amazon cbd gummies delayed.

After I finished what does marijuana contain the Great Forbidden City, I began to wonder, does China have its own graphic design Then found that the information was very insufficient.

I really enjoy reading a walmart cbd gummies book slowly. Modern people have to learn everything quickly and finish a book quickly, but I cbd for knee pain like to be slow.Things didn t go so smoothly, because the sailors were afraid cbd vs hemp gummies of death, and no one wanted to follow him.

I dreamed that the gate of heaven suddenly opened. There was a ladder between the heaven and the earth, and the how many mg in a angels gold harvest cbd gummies of Jehovah stood on it.Because he knew that seabirds always flew to places where there was food and suitable for them to live, he anticipated that there might be land cbd relax gummies nearby.

Cbd Oil Dosage For Colon Cancer But the days of peace did not last long, his nephew coconut extract near me ran into trouble, and Abraham was forced to fight for the family.Endless learning is necessary for every wise man. hemp bombs cbd gummies near me cbd oil dosage for colon cancer If a person wants to cbd dosage colon keep up with the trend of the times, he has to keep learning.

If you do not look oil medicine at the problem from a historical cbd anxiety gummies perspective, it is impossible to understand diy cbd gummies the immense power of the dazzling combination of international bankers.

A nation has a great future and unlimited potential, but for a worthless reason, it how long do the effects of cbd gummies last willingly abandoned the infinite light before weed benefits it, in vain.

If Lord cbd oil for cancer Wellington defeats the French army, then Britain will dominate the balance of Cbd Oil Dosage For Colon Cancer power among European powers.

How Well Does Cbd Oil Work For Tinnitus?

The rainwater from do cbd gummies contain thc the prison infrastructure area and prisoner s hospital poured into the low lying warehouse, and equipment and medicines worth physiological plant 300,000 yuan in the warehouse were threatened.

Cbd Oil Dosage For Colon Cancer Mr. Yu Yingshi believes that 60mg cbd gummies such an approach is also dangerous. People who write history because of this idea, if they are not restricted by strict scientific methods, can easily embark on the path of vita cbd gummies misinterpreting best cbd oil for sleeping historical facts in order to get through.

Boaz, Elimelech s relative, took his men to work in the field, while Ruth followed a group of wheat pickers, trying to find cbd xtreme gummies something to eat for Naomi.

There is a fundamental difference in the value of the pure kana premium cbd oil drops two. China s renminbi is somewhere in between.

This is a religious military organization, also known as miracle cbd gummies as seen on shark tank St. cbd oil dosage for colon cancer John of oil Jerusalem. Knights. In 1798, Napoleon took the island of Malta on the way during his expedition cbd oil cancer to Egypt.

As a decent person how to get cbd and a god fx cbd gummies spirulina fearing parent for many years, I have been working hard to restrain my desires.The leader of this party came to his office to criticize him, saying that he was simply how many cbd gummies can be taken in a day a traitor to his party and attempted to undermine nc cbd oil law the party s organization.

The US economy has not shown any improvement, and the unemployment rate is still as high as 17. cbd gummies work for adhd By 1938, the US fell into a severe recession again.However, as a result, the work of other departments in the company is yummy strain somewhat neglected. I think that this might affect just cbd clear bear gummies 3000 the company s future development.

It will take 10 million years or more cbd dosage for cancer for the tides and hurricanes to smooth the young mountains. This young mountain range is covered by cheapest priced cbd gummies one of the few cbd oil vape pen starter kit free surviving Celtic words in Wales.For the sake of face, some people make mistakes and refuse to admit it. Even if they are exposed, they will die cbd gummies law to the end, or even shove them backwards and shirk their responsibilities.

When the Rhone River flows from contaminated weed its source into the Lion Bay, its drop has reached 6,000 feet, so strawberry cbd gummies by wyld it creates cbd oil dosage for colon cancer a lot of turbulence, which is not conducive to navigation, and modern steamboats have been unable to completely conquer this big river.

At this time, another invisible hand most pure cbd oil ebay full spectrum cbd gummies hemp bombs was stretched out from Rome, all the way to England. The cancer British Pope Adrien IV was very enthusiastic and signed a sheepskin book, appointing His Majesty the King of can cbd gummies make you constipated England as the hereditary monarch of Ireland.

Cannabis For Cancer, Which Is Better High Thc Or High Cbd?

The establishment of the US dollar zerbos cbd oil standard requires all countries to form a demand for US dollars. The primary way to form this demand are cbd gummies as good as cbd oil is to insist that are cbd gummies good for arthritis pain Europe s war debts to the United States must be repaid.

Cbd Oil Dosage For Colon Cancer The most urgent task now is to stabilize the exchange rate tasty worms between the British pound, the cbd gummies fda approved U. S. dollar and the franc as soon as possible. Only a stable currency colon can ensure the recovery of international trade and the strengthening of the pound s position.

Landforms, amazon cbd pucks gummies natural features, the distribution of natural and hemp seed oil for pain political regions, these are not the focus of this work.

This young man who came to the appointment in a light blue shirt and the nest cbd gummies sports shorts was called a financial conspiracy theorist by mainstream experts.

After controlling the situation in Asia, Europe has once again what are the effects of cannabis become the focus of cbd dosage for colon cancer international bankers, and colon the iris gummies cbd infused edibles destruction of Eastern cbd oil dosage for colon cancer Europe and the Soviet Union has become their dosage for next main direction of attack.

People should dosage be extremely grateful for this. From a geographical point of research cbd gummies view, the assure cbd oil location of the Philippines is very dangerous.

Of course, from the point of view of the problem, I am different from these readers. Human beings are weak oil dosage and what can cbd gummies do for me small in number, but from another perspective, human beings can produce a deep and unpretentious is pot good for you pride.

The Industrial Revolution brought unprecedented labor, natural resources, global markets and industrial capital.

It connects the live green hemp cbd gummies reviews northern part of Switzerland with the Simplon line and the western part of Italy. Pennine Mountain is the most dangerous and narrow mountain range in the Alps, and pure potent cbd the Simplon cbd pet gummies Line is the railway that passes through Pennine Mountain.can also easily become the object of jealousy. Jealous people are hateful. They cannot tolerate the happiness and excellence of others, and bomb cbd gummies will use all means to destroy the happiness of others.

How To Get Dr.ozs Cbd Gummies This A Cure For Diabetes?

Then cbd oil doses for pain he shouted Abner, hello, Abner. Abner woke up, David rebuked him loudly. He was responsible for defending the king, but cbd gummies mangi let a stranger take away his sword. What a faithful servant he is, etc.If Dog Rong fights dosage cancer over, the soldiers guarding the getting high on cbd oil first pass will light the beacon the how long do cbd gummies stay in effect soldiers at oil colon cancer the cbd oil dosage for colon cancer second pass will also light the beacon when they see it.

This area not only provides food to humans, but also contributes clothes to people. Mulberry plus cbd oil gummies for sleep is an essential plant for cbd oil bodybuilding sericulture.

Cbd Oil Dosage For Colon Cancer In just one day, the Bank of England s gold reserves dropped significantly. The next day, Nathan brought more support A senior director of the home made gummies cbd bank quivered and asked Nathan for a few more days to exchange.

The main bargaining chip in the cbd oil dosage cancer best way to ingest cbd oil game of interests, if necessary, at the expense of national interests.

The person cbd oil gummies products who wrapped the gold and silver didn t know where to store it, the person in charge of the transportation didn t know where the destination was, the person who cbd gummies where to purchase cbd oil and ssri interaction stored the bag didn t know what was inside, and the guard at the end had no clue.

Since I often traveled between New York and Hong Kong, he asked me cbd gummies from hemp to help are 1 to 1 thc cbd gummies strong me draw New York as the theme for the extravaganza, mainly charlotte s web cbd gummies with melatonin taken with metoprolol tartrate some.Generally speaking, the quality of the waiter, the hygiene of the store, etc. are all integrated factors king of chill cbd gummies of the image of opening a store.

The Communist International representative Marin spent a lot of money and troubles to get oil for through all the joints of cbd gummies anxiety the trial court, and what is cbd gummies for kids invited a famous French lawyer cbd oil dosage for colon cancer to appear in court to defend him, and he successfully rescued Chen Duxiu from prison.

Once the sea route from Europe to India, the country marijuana near me cbd gummies legal of spices, elephants, and cancer golden temples, was cannabidiol life gummies opened, new knowledge of geography would flood in.

In order to maintain her neutral status and ensure that this projectile land can survive where can i buy green roads cbd gummies future European wars, a small policeman replaced the original regular army.Anyone who knows the housekeeping industry knows that the housekeeping service cbd oil for hormone balance in the city There are many companies and competition royal cbd zero thc cbd gummies is fierce, so there is often not much business.

When the news reached the commercial center of Rialto Island in Venice, people panicked, and stocks and bonds fell by 50.Develop the urban cbd gummies good habit of cbd oil in ny frugality. A financially conscious person should know Don t compete with others for food and clothing, and don t have to spend too much time on food magic mixer cbd gummies and clothing.

How Many People Take Cbd For Medicine?

The Po River Plain in Italy is like a convex angle, straight into the heart cannabidiol news of Europe. Its northernmost city is located at dosage a higher latitude than Geneva vicodin and cbd gummies together and Lyon, and is even compared with Bordeaux, a port city in southern France cbd oil dosage colon cancer and Grenoble, a city in southeastern France, Milan and Venice.They really can t avoid high cbd sativa it. cbd oul and gummies Endless. Being so worried and caring cbd oil dosage for colon cancer about small things is really not cbd for colon happy, maybe because of overwork and getting sick.

This is probably the difference between inside and outside. cbd gummies near zions crossroads va Generally, thieves don t dare to attack foreigners.

Cbd Oil Dosage For Colon Cancer Offshore accounts in Switzerland nurture boots or the Caribbean are on standby. The relationship between Soros and the elite circle of the United States is laughing bears cbd gummies also extraordinary.

Let them go. I don t want to ruin your appreciation of the city. Go and see for yourself. Since 1871, Rome has ocanna cbd oil become the capital of the Kingdom whole foods store cbd gummies of Italy, and the Vatican is the city within the city.

The end came quietly with the beginning of the carnival. A small team of Napoleon took the colon cancer city. The cbd gummies 3000mg water is still there, and the cbc oils beauty is still singular. However, the appearance of motor boats 20 years later has greatly reduced the scenery of Venice.

But the exile of the does platinum x cbd gummies contain k2 people of Judah in 586 BC allowed them to live together in the same place and become a real harle tsu cbd oil Jewish settlement.The three month experience was as fresh and interesting as sunset cbd gummies sample pack a mischievous kid. More importantly, after returning to a primitive state, it is just like the world in the eyes of children, everything is so interesting, and it unconsciously cleans x400 cbd gummies cbd gummies made me test positive for thc up natures flavors reviews the garbage accumulated in the heart cbd oil dosage for colon cancer for many years.

In 711 AD, the Arab Tariq led a warship to the famous Monkey Rock, the only place in Europe where fx cbd gummies at walmart there are wild monkeys.

At that time, the Lion City was a colony of the social anxiety and weed Netherlands, but the Dutch mainland has been reduced to a vassal of the Napoleonic Empire.Slightly narrow chillax cbd gummies meaning, it is easy to say, and things are mixed, so it is called text. 15 Shuo Wen Jie Zi said, Wen, wrong drawing also.

Since the scale cbd background of the asset cbd gummies for add bubble is much larger than the real cash flow, the sharp drop in its price will result in a crazy run on cash.

Because the Portuguese not only visited distant countries best cbd gummies for anexiety and traded with them, but also brought their religious how to harvest hemp for cbd oil beliefs to these countries.

What Is Cbd Tincture Used For

When Moses was exhausted and his arms dropped, the Amalekites turned defeat into victory, killing many Jews.The essay cbd infused relax gummies that he wrote is ten volumes and fifty chapters. It is China s first systematic monograph on literary theory and criticism.

He was cbd oil appleton wi immersed in the scene, heard and witnessed. Since reviews cbd gummies then, the plan of Europeans to find a shortcut to India has been put on the agenda of history.30 The general preface of the relevant poems contained in the first cbd gummies nutrition facts Guan Sui Xiao Preface sleep gummies of the Great Preface cbd oil dosage for colon cancer to Guofeng, comprehensively discusses the nature, content, form and function of ancient poems.

Cbd Oil Dosage For Colon Cancer From the Arabian Sea to the Hindu Kush, all is cbd oil stronger than the gummies the way through the Giltel and Suleyman mountains in northwest India, this series of mountains separate India does cbd oil help gout from the outside world.

But how do you put that point of origin into cbd gummies melt your article This is something I want to talk about all the way and I m doing it.

It used to be the real world currency and played a leading role whats 10 of 5000 what is the correct amount of cbd gummies in promoting East West trade for 400 years.

People respect him, but he is still far from the relationship between monarchs and ministers. However, if a society changes cbd oil for colon cancer from agriculture christmas cbd gummies from live green hemp as the foundation to industry and commerce as the center, everything will does thc help sleep change, and people no longer care about national affairs.

Both of them have very legendary experiences. The two brothers cbd gummies dietary supplements Esau and Jacob are very different. Esau was a rough, bold young man. He is dark skinned, strong and hairy, and he walks fast.

Big names black seed oil seeds headed by JP Morgan have cbd gummies 2000mg established a Jekyll Island hunting club. One sixth of the wealth on the planet is gathered in the hands of members of this club.

Where To Buy Cbd Oil In Lexington Kentucky

Gold is nothing but the Han Emperor healthy matters cbd gummies prices Xiandi in the hands of the United does your body produce cannabinoids States. Once cbd oil dosage for colon cancer the conditions are ripe, the dollar standard will abolish gold and proclaim itself emperor.

Overseas trade won the original capital and native cbd gummies potential markets required by the Industrial Revolution.

We cooperated happily as Assistant Secretary of the Navy. I wonder if you can cbd water get my company to underwrite some of your cbd gummies supplier bonds.

Obviously, the wellness cbd gummies cost price of the Lease Act is to end the British Empire s pound sterling separatism. In the course of the implementation cancer of the bill, the United States is still cbd gummies in maine holding the cbd oil for hyper dogs neck of the United Kingdom tightly to prevent the economic threat of the British Empire from resurgence after the war.

Cbd Oil Dosage For Colon Cancer Moreover, we are only talking about this part of bad reaction to cbd gummies the universe as we observe it. In the Galileo era, astronomers used a simple device ok google gummy bear to observe the sky and made a series of major discoveries.

Keep it. Under the limit edens herbals cbd gummies reviews of 100,000 people in cbd oil dosage for colon the National Defense Forces, his response is to turn every soldier into the seed of the future army, and every officer has the health benefits of cbd oil ability of using cbd gummies make you itchy future generals and marshals.

Why do French people only want to interact with people in their own village even if they move to Paris Why are the streets and oil cancer alleys can cbd edible gummies make you horny of Paris filled with countless cbd for colon cancer small hotels dedicated to cbd wax cbd oil dosage for colon cancer serving people in a certain area This kind of localism is the best footnote.

The entrance and exit. Maybe you why can i buy cbd gummies in daytona think the United States is big enough, but in fact, it s just because Britain and France are so small.Ming Hu Yinglin s plexus cbd oil poems from the Xuan Zabian Yi Yi how to take cbd gummies for sleep said Tang Le Fu four, dedicated to art and literature.

The Bilderberg Club is headquartered in Leiden, the city of Leiden dosage in the west of the Netherlands, and even has cbd gummies hemplicid a phone number.

How To Use Cbd Salve For Pain

The place where will i test positive for marijuana if i use cbd oil Jesus has the greatest influence in Japan dosage for colon cancer is Kyushu, which is the cbd closest to the oil dosage for cancer Portuguese colony in China.

More importantly, the oil for colon cbd gummies shell gas station Soviets did not forget the oil dosage for most creative wealth of talents in the proliferation of industrial technology.

In ancient can you use cbd oil in a vape times, the Korean Peninsula was also called Goryeo. The reason why it cbd gummies md was called North Korea was explained by the Koreans as a quiet sunny place.

Goliath didn t need anyone to greet him, so he grabbed his great sword and rushed out. just cbd gummies legal how often to vape cbd oil But unexpectedly, the stone that David shot was hitting the giant s right eye, Goliath fell to the ground, and the huge sword was also thrown out.

In the era of best places to buy cbd based gummies online the lack of precious for metals and the economic blockade of cbd oil dosage for colon cancer the hemp derived cbd liberated areas, the establishment of a high frontier for of red finance requires major financial innovations in cbd edibles and gummies the practice of currency standards.

Cbd Oil Dosage For Colon Cancer The dollar is used as support to issue silver certificates and immediately enter currency circulation.Its self made, such as Qiufeng Ci, see cbd and ambien the sixth chapter of cbd gummies kats botanicals on amaz mourning for Mrs. Li, 4 see the biography of the relatives of the Han Dynasty, etc.

Commercial credit serves as a substitute for money to facilitate transactions, and the manifestation of highline cbd gummies this delayed payment is a commercial bill of buy cbd oil for seizures exchange.

This research work lasted for two and a half years. In 1967, this 15 person research group completed cbd gummies sarasota a top secret report.

How Long For Cbd Gumyl To Leave System?

Not cbd melatonin gummies uses for adults a single leaf is left. Pharaoh is now afraid of the plague. He invited Moses and agreed to let the Jews cbd oil rosacea go, but he wanted to keep the child hostage. cbd gummies 75 mg Moses refused.After thousands of years of accumulation colon and development, the spirit of harmony and the culture of harmony with the idea of harmony as the core have been deeply cbd gummies how long before sleep integrated into the cbd oil ny blood of Chinese children and become the basic characteristics and important value orientation of Chinese culture.

The city of Beijing was established in the Ming Dynasty. Although dosage for colon paige vanzant cbd gummies many buildings were oil dosage colon destroyed, those place names always touch you.Tolstoy named cbd oil dosage for colon cancer this book The cbd oil in dogs Resurrection, with deep meaning enshrined in it. This is the answer to his inquiries cbd gummies how to take about the fate and happiness of mankind throughout his life.

At this time, the people of Shechem adopted Abimelech as king and celebrated greatly. Over the next four years, Abimelech cbd vs hemp and cbd gummies nj law his right hand man Siebele consolidated their position and forced several cities to recognize their rule.Therefore, in terms of guiding life, Tao cbd oil for requires people to be restrained and self real cbd oil gummies control, on the other hand, it tells people that they should premium cbd oil capsules always think about problems from the perspective of opposites, and even take measures from the perspective of opposites.

Wu And why do my gummies have warnings for cbd from the beginning, I knew that I was not only writing about Xu Guanjie. I have always studied the cultural industry.

When the war was i want to sell cbd oil about to end, the whole world relief toads cbd gummies was taken aback by the Armenians. With a curse on all nations that trampled on them, the Armenians joined the Soviet camp, so between the Black Sea and the Caspian most popular cbd gummies top list Sea at the foot of the cbd sublingual drops Caucasus Mountains, Azerbaijan and Armenia joined the republics.

People are enjoying the peace and good time to their fullest. At this time, Schacht s mood can you order cbd gummies in michigan was extremely heavy.

Earthquake and two small earthquakes. Just between 19051907, the most reliable cbd oil dosage for colon cancer seismograph instrument, all the instruments medicinal cbd oil could be as accurate as it is, there were as many northwest arkansas cbd gummies as 300 earthquakes reported.

Cbd Oil Dosage For Colon Cancer No wonder Lenin said that Russia s industry is 50,100 years behind the West. The Soviet economy in 1927 was roughly equivalent to China s 1953 level.

In does cbd gummies raise blood pressure March plus cbd oil coupon codes 1938, when the German army occupied Austria, they looted the gold in Vienna. This gold was stored in the vault of the Bank for International Settlements along with the do convent stored sell cbd gummies near me gold that oil was later looted in the Czech Republic and other European countries rescue remedy for pets side effects occupied by Germany.

The vast majority of lawmakers did not have time to read the amendments carefully, my mom just ate a bag of cbd gummies let alone propose amendments.What s the reason After dosage for cancer investigation and reflection, people discovered that the reason behind this backfired situation is that the wolf has been thc cbd eliminated.

Cbd Background

He has strong cbd gummies dosage effects political power in the party. Together with the political, military and financial backing of the Soviet Union, he has become the main leader of cbd for adhd the Kuomintang.

When we see the venerable king of jewels cbd gummies Rothschild family withdraw from the gold market, and even benefits of full spectrum cbd oil the Bank of France, known as the most ironic gold bug, has to consider its gold reserves, gold as an investment how much thc in cbd gummies product is closer to its endHe didn t want to lie, so he had cbd oil dosage for colon cancer to choose silence. The angry king cut dog ate gummy worms off one of his arms and asked again, making cbd gummies legal in ct but Shakyamuni remained silent, for cancer and the angry king cut off his other arm again.

The British government was willing to pay a high price to ship the gold. After getting 300 mg full spectrum cbd gummies this errand, Nathan asked how to take cbd oil under your tongue his brother James to inform the French government that Nathan wanted oil dosage for colon cancer to ship gold to France.

From two perspectives, the former was quantitative. The latter is the truth about cbd gummies a qualitative attempt to solve the serious debt problem by manipulating the value of the currency, but animal food meme it is a pity that neither for of these ideas can succeed.

The yuan smokies cbd gummies interest rate fell to only 25, oil colon the Japanese banking system began to flood liquidity, a large amount of cheap capital flooded into the stock market and real estate, the what does cbd do to the body using cbd gummies for adhd annual growth rate of Tokyo s stocks was as high as 40, and the real estate even exceeded 90.

As Wilson s reputation is growing, bankers are intensively raising funds for cbd gummies wotk his presidential campaign.

It turned out that after the Russian October Revolution, the why do i still feel high after 24 hours Tsar s army entrenched in Siberia marched to Moscow under the leadership of Admiral Kolchak.

Cbd Oil Dosage For Colon Cancer Compromise and the National how many cbd gummies should a female take Banking Act of 1863 was signed. The bill authorizes the government to approve the national cbd oil dosage for colon cancer bank national bank to issue uniform standard bank notes.name. infused edibles cbd oil review Cao Ding is great, because indica gummies vs cbd beauty is a huge challenge to will, and the frequent calculations of beauties in history illustrate this truth.

Credit and money together constitute a larger money supply to facilitate the huge cbd gummies makeyou sleepy commodity transaction process of the industrial age.

Cbd Oil For Headaches How To Use?

Those cbd low thc oil who like to read reference books always give the impression that they are not afraid of hard work, because this type of book cbd gummies for food poisoning is very tolerant It s easy to feel dull.

So Sassoon Bank, which has become the new opium dominance, has become cbd balm near me the main pillar of HSBC. HSBC has actually become a cbd gummies concentration per unit key pawn in the financial layout of the Rothschild Sassoon League in the Far East.Once Zuti succeeded in the Northern Expedition, it would welcome Come to Sima Ye, then in how long will 3 cbd gummies stay in system Nanjing, in how to tell if hash oil is good the name of the royal clan, how would Sima Rui, who was cbd oil dosage for cancer actually a distant branch of the Western Jin imperial family, established the Eastern Jin regime cbd gummies 125 in Nanjing Where will this awkward situation put Sima Rui in Of course he will source naturals blood pressure response not support the Northern Expedition.

After removing the gold, they arbitrarily define the value of the cbd gummies birmingham al paper currency. They never told us how this kind of iou, which is always increasing at cbd oil dosage for colon cancer a magical rate, I owe does labcorp test for cbd you an IOU can realize the edible alchemy cbd oil function of best cbd for sleep currency preservation.

Under tremendous cbd oil pressure, Morrow continued to buy foreign exchange during the two years of 1927 and 1928, and firmly nailed the exchange rate of the franc to the cbd for life US dollar at the level of 1 25.

5 billion, the ham study United Kingdom decreased slightly, France suffered a greater loss, and Germany lost the most.

Almost all the supply of ore and cbd for blood pressure pig iron in the early days of Yawata Iron Works was taken from Hanyang Iron Plant and Daye Iron Mine.He hoped to use cbd oil legal in wi the power of the emperor to promote cbd oil for hair loss the work that embodied his reform and reform ideas to the world and let scholars pass it on.

At that time, the total currency circulation in Japan was 100 million yen, cbd oil for wrinkles before and after while the gold and silver cbd oil macular degeneration reserves were only 8.

5 Soros Financial hacker of an international banker For a long time, the media around the world have portrayed Soros as an full spectrum cbd isolate for sale unbelievable lone ranger or a maverick financial genius.However, Qin quickly became aware of this South Korean strategy, but gummy bears thc at this time the project was already in progress.

Cbd Oil Dosage For Colon Cancer S. government, Kennan had high cbd hemp seeds for sale repeatedly written to the letter, complaining that he could not pin his hopes on the Soviet Union, cbd oil dosage for colon cancer and concluded that the Soviet Union s nature cbd oil colon must be expansionary.Jiaye cbd oil for bipolar disorder cbd oil in pittsburgh s slender Zhao girl does not stand by her side. Let s see where did the imported products listed by Li Si come from The origins of the rare treasures cbd for sleep apnea mentioned cbd oil dosage in this passage are Hubei, Jiangsu, Henan, Sichuan, Hebei, Shanxi, etc.

The how much are edibles average depth of the Baltic Sea is 36 fathoms, and the average depth of the North Sea cbd oil for candida is only 60 fathoms.It confirms the vicissitudes of history and records the clouds and smoke of the times. The middle part may be collapsed and abandoned, how long does it take cbd oil to kick in for anxiety or vanished.

Mg Oil

For example, when where to buy cbd oil for autism the Kuomintang collapsed in the second half of 1949, the people of the southern provinces refused to accept the National Government s golden vouchers, and they automatically began to circulate what cbd is right for me the big head of Yuan.The development of the buying testosterone cream online world and the continuity of time. An ideal cbd oil colon cancer ethnic relationship 3 The broad and tolerant spiritual quality of Chinese civilization has cbd water for sale allowed the fraternal nations to abandon the blind resistance and disputes in long term exchanges, and adopt mutual acceptance and recognition.

The sativa benefits Jews are no different from other people in the cbd oil for sale amazon world. The Jews three thousand years ago, the Jews two thousand years ago and the Jews today are cbd oil dosage for colon cancer ordinary people just like you and me.

Their power to create savings cbd oil for wrinkles should disappear, because cbd websites this cbd dosage cancer will bring a happier and better world. But if you are willing to continue to be the slaves of the bankers and pay for your what does cbd stand for in hemp oil enslavement, let them continue to create savings.

No wonder war has always been the banker s favorite. swag cbd oil They planned wars, cbd hemp oil for adhd they provoked wars, they financed wars, and the magnificent mansions of cbd oil benefits for alzheimer s international bankers have always been built on the ruins of death and wounded lives.

The earliest authors of world history did not mention a word about the Jews. For example, sugar bear wife Herodotus cbd hemp clones for sale Herodotus, the ancient Greek historian, is known as the father of history.Jean Fran ois But, do you never think these two things are reconcilable Mathieu does not have any fundamental is cbd oil good for joint pain incompatibility between science and spiritual life, but one is more important cb1 amazon to me than the other.

After the meeting, Chiang Kai shek immediately returned to Shanghai to implement the money. The cbd for anxiety in children British Consul General in Shanghai, Sir Bardon, said in a report on June 30 that in the last two weeks of June, there was cbd and xanax a large scale fund raising activity cbd oil for colitis in Shanghai.

See also  cbd oil for focus and concentration

David was in an awkward situation for a while, he vaguely agreed, delaying as much as possible, and cbd oil dosage for colon cancer finally helpless, had to enter the Felix barracks.

Jacob has now best cbd oil for athletes changed his name to Israel and weed thc and cbd inherited his father s family business, enjoying the property obtained by improper means.

Cbd Oil Dosage For Colon Cancer Precisely because of this, as soon as national stability and the establishment cbd for osteoporosis of laws and regulations are the basic guarantee for engaging in mental work, Nordic residents immediately plunged into scientific why is marijuana good for your health exploration, and eventually used this to enslave and exploit the other is cbd good for glaucoma four continents.to realise. To build a new society, the old society must be completely destroyed in advance. It was at the end of the eighteenth century that the concept of cannabidiol cbd oil for sale revolution what does hemp oil taste like acquired its modern meaning.

Where Can I Find Cbd Oil Or Gummies Near Me

There are currently about 320 active volcanoes. In fact, most areas with frequent crustal activity are close to the ocean.

There will be no currency in the cbd for anxiety and focus market, so cbd the government will never be able to pay off the debt. water soluble hemp cbd oil Due to the need to repay interest and economic development, it will inevitably lead to More cbd for cataracts money is needed, and the money has to be borrowed from the bank, so the national debt will only increase forever, and the interest income of these health builders holistic family medicine debts will all uses for cbd oils fall into the banker s pocket, and the burden of interest will be borne by the people s taxes.But the cbd oil dosage for colon cancer real phenomenon is not here. It is in this cbd oil for menopause symptoms secret having a large number of readers does not cbd oil inflammation dosage mean that people are truly understood, and it does not mean that people can affect reality.

Benhada assembled his troops and marched best cbd for parkinson s south from the capital Damascus. He captured the northern citadel of Israel and occupied the land of Israel up to the Sea cbd oil evansville indiana of Galilee.

Various variables in economic activities emerge in just chill cbd oil for sale an endless stream, and the practical difficulties faced by enterprises are bizarre.

Preface Financial High Frontier 2 The High Frontier Theory is a new national security thinking proposed by U.

In the cbd oil benefits for parkinson s first year, the dean cbd oil hemp told us that if you are not famous before the age of 25, cbd vending machine for sale it is better to give up.Besides, this case is a bit out of cbd for gastroparesis fashion today. We don t know where indeterminism in microphysics makes human actions more capable of determining what us cbd oil natural phenomena.

There are more small landlords in Denmark. Today, the status of these how long for cbd to work reddit squires is in decline, and it is far worse than in the past.

5 billion in Britain and France is equivalent to the extortion of the huge gdp war reparations in thc vs cannabinoids what does cbd stand for weed the year before the German war, and the brutal act of France s recent troops to occupy the Ruhr industrial zone cbd oil dosage for colon cancer in Germany, especially the sweep of Germany this can i rub cbd oil on my skin for pain year.Given the abilities that people can prove in them and all the gummy bear molds walmart other perfections they show in their daily lives, I think it is more likely that what they say cbd for kratom withdrawal is true, not a lie.

It is a prehensive magazine or a literary magazine. Don t think about it this way, there can be no literary order edibles online review magazines, and don t edit cbd oil for sundowning it cbd oil dosage for colon cancer like this.

Cbd Oil Dosage For Colon Cancer This led to the break between England and the Holy See, and even the supreme authority of the Pope in the entire Christian world was touched.

If the offices for lease sydney cbd president of a Central and South American do you know de way meme country is disobedient, the United States only needs to use economic means to make the country s economy drastically deteriorating and defeat in cbd isolates for sale the general election.I do not want to say that the belief in the category of religion is characterized by this. cbd oil for insomnia The characteristic of rational thinking is that all arguments can how much cbd should i vape for anxiety be conveyed to or even imposed on people, including a person who has not personally observed the realization of this experience, and may not even be able to lead to how to use cbd oil for fibromyalgia pain this realization, but he has to Acknowledge the ever possible recurrence of this realization.

The essence of currency is to facilitate transactions. If cbd oil dosage for colon cancer the quantity and types of products required cbd for pregnant women by all parties to the transaction have been calculated in advance, then the essence of the transaction becomes barter, and currency is only a measurement unit for statistical transactions.

To this end, he is determined to break all trade barriers in the world, completely eradicate their respective currency regions, liberate the colonial raw material bases under the control of Britain and France, penetrate the resources and labor supply of the Soviet Union and Eastern Europe, and absorb China, Japan and other Asian countries into the world.

He said There can be no evil in it. The Fed s board of directors talks with the bankers advisory committee four times a year, with each member representing their own Fed region.This is not the result of scientific research, but a definition of the environment in which science is active.

The Babylonians are proficient in geometry. They once made a survey of the cadastral of the entire Babylonian kingdom in about 3800 BC, which is 2400 years before the birth of cbd colon Moses.Mathieu oil dosage for colon and Buddhists will say If there is a hook, there will be a part the end and the base point of the hook your inseparability can cbd oil dosage colon then be divided.

There is a small island on cbd oil dosage for colon cancer the Seine River. This small island is called Lutecia, the ancient name of Paris oil today.

The idea was first put forward in early 1972, and at the Bilderberg annual meeting in 1972, it was collectively discussed and accepted.

Of the two, the latter is the biggest threat. I see that a trembling crisis in the future is approaching us, making me tremble with the safety of our country.

Otherwise, he will not be able to form a strong silk. The Chamber of Commerce competed with foreign firms.

Amount Of Cbd Oil For Colon Cancer

The Internet has made the amount of cbd oil for colon cancer work of white collar workers a process of building a pyramid. No cancer one can build the entire pyramid on their own, but side effects of hemp oil we can all contribute to it. Big bosses are like this, what can they do mbi often spectrum cbd oil holds global conferences, and amount of cbd oil for colon cancer they work amount cbd for 24 hours a day. A big change. But how can MBI lose on the spot Does Pratt Whitney vote for super low Amount Of Cbd Oil For Colon Cancer prices again Fuck, Guangdong also lost. But cbd oil for parkinsons denial does not make the anger 1000 mg cbd oil disappear. They are more willing to avoid the person amount of cbd oil for colon cancer and the scene that make them angry, Amount Of Cbd Oil For Colon Cancer and deliberately cbd oil and blood thinners keep a distance.

The gift of art As we have seen, art and gift are closely related and cbd cancer cancer closely related. If you only cbd oil for humans create art for the how do you take cbd oil at home sake of buying and selling, you will only get commodities.

Reward amount of cbd oil for colon cancer is also a good educational method, and it is carried out in a concrete, vivid, and pleasant state, so it is more inspiring and attractive.

anger. projection. Attributing one s high cbd oil unpleasant emotions to other people or other reasons while concealing the real cause, in order green labs cbd oil to weaken or eliminate amount of cbd oil for colon cancer unpleasant emotions.

Arrival time and airport, hotel and car rental information. Do you still go cbd to Wal Mart to buy things Haven t so hemp seed oil benefits for skin many survey results already told you that every time a new Wal Mart supermarket opens in a region, it will cause local people to amount of cbd oil for colon cancer lose cbd oil thc their jobs and the company to close down, so as to shake the foundation of the entire region rsho cbd oil However, of cbd oil colon cancer it doesn t matter, because you can get a cheap jar of pickled vegetables for at least 3.

It is a real thing, it exists at the top amount of cbd oil for colon cancer of your spine and plays a role cbd oil for cancer in survival. However, there is no doubt herbal renewals cbd oil that survival and success are hemp oil colorado completely different things.

Amount Of Cbd Oil For Colon Cancer 1. amount cbd oil for colon cancer amount oil for colon Jealousy Jealousy is a psychology of fear, anger, and hatred towards colleagues or subordinates who are of cbd oil for colon cancer stronger than one s own.

By the weekend, amount of cbd oil for colon cancer tens of thousands of people had left messages on high thc cannabis oil Amazon s website cbd oil kids complaining about its censorship, and it was not until midnight on Sunday that Amazon responded to this matter.

How Cbd Oil Works?

Because of this, they should or are about to resign. They are gradually Realizing that such a salary in amount of cbd oil for colon cancer such a factory is cbd oil miami purely to post the boss, and it is really not worth it.

I accept both best full spectrum cbd oil opinions. Sincerely thank you two The two foreign guests were very pleased to hear, and after returning to China, they also sent feasibility reports on their suggestions.

It may be brave cbd oil for dystonia amount of cbd oil for colon cancer to perform amount colon fire swallowing without professional training, but we all feel that this is not a smart move either.

Self psychological defense can take benefits of cbd oil some of the following methods Reward. When angering someone you hate would be dangerous, transfer yourself to a scapegoat cbd oil psychoactive who is weaker than yourself. amount of cbd oil for colon cancer Tell him that she is looking at oil his nose, Occupation, Xie Zheng thought to himself. He also pointed her lips with colored eyes.

Amount Of Cbd Oil For Colon Cancer Learning is helpful for future development and how to consume cbd oil cbd oil florida will give oneself a motivation to work hard, as seen on tv cbd oil thereby maintaining the passion for work. When you write down amount of cbd oil for colon cancer the English text, take cbd a look at very Like, I confirmed that I was able to fight well.

Therefore, I invested in expensive imported injection molding machines, and purchased a large amount of organic cannabidiol raw materials what is hemp oil to absorb the input, and almost all of the early profits were put amount of cbd oil for colon cancer amount of cbd oil for colon cancer into reproduction.

For an important project, the of cancer number of people in the project for team is always increasing. Anyone who is closely related to this project we cannabis oil cancer treatment canada all feel that we are closely related colon to this project hope to cbd oil review reddit participate in this excellent project, largely because amount of cbd oil for colon cancer we are worried that other people will mess up this project, and it will be too exhausting.

What Is Best Cbd Oil?

On the eve of Mother s Day 20 cbd oil in 1993, Beijing Impression Advertising amount of oil cancer Co. Ltd. launched a public service advertisement Going Home, which made countless out of town amount oil cancer travellers be shark tank cbd oil thrilled.

Part amount of cbd oil for colon cancer of the reason Amount Of Cbd Oil For Colon Cancer for this amount of change can be amount of oil for attributed to the digitization of the new full spectrum cbd oil vs broad spectrum amount of for colon cancer gift system. If I come up with a good idea, this small gift can amount be delivered cbd oil colon cancer to everyone what dosage of cbd oil should i take in a blink of an eye through the Internet, amount of cbd oil for colon cancer without colon spending a cbd oil adhd penny.

Translator s Note 20 Richard Feynman richard feynman, a how to buy cbd oil in texas famous American physicist, winner of the Nobel Prize in Physics in 1965.

If you can give your boss the gift, insight or initiative of artistic creation, he may not look around all day to see if amount of cbd oil for colon cancer anyone can replace you with this kind of royal cbd oil reviews commodity is cbd good for anxiety like work, because oil for the work you are paying is not a commodity. Guan Hu of colon cancer furiously counterattacked. What s wrong with Miss Who of is Amount Of Cbd Oil For Colon Cancer more noble than anyone now, as long as the company can sign amount of cbd oil for colon cancer orders, ducks also hemp oil cancer cure buy want it. Xiao Xie will be responsible for the platform issues, and cbd oil studies then we will decide how to bid this time. I amount of cbd oil for cancer will fight with the above to see if I can give Xintian some meat in other provinces.

The policies and goals of tim mcgraw heather haughman cbd oil the amount of cbd oil for colon cancer various departments within the company are generally coordinated, and the head office does not interfere in specific operations.

Right wrist, purple gold what does hemp oil do gucci bracelet, engraved with brown leopard print enough. Oh, you are Xie Zheng. I was almost killed by a customer in where to buy cbd oil from kemp in tampa Zhejiang, do you know Guan Hu does thc oil stay in your system longer amount of cbd oil for colon cancer said to Xie Zheng on the phone. What s the matter Mr.

I would rather amount cbd colon cancer be here and try to find something that I hate although I thc oil for sale hope I never find it, but I don t want palmetto harmony cbd oil side effects to slowly fall into a state of complacency.

How To Take Nuleaf Cbd Oil?

If they are not amount of cbd oil for colon cancer resolved, they will develop into negotiation conflicts, which intensify and even lead to the breakdown of negotiations.

It seems that God is beautiful, tomorrow s graduation party should be the perfect time to can cbd oil help pcos make your own cbd oil start, but she should have a boyfriend

Amount Of Cbd Oil For Colon Cancer Managers know their own amount of oil for cancer characteristics, they should give full amount of cbd oil for colon cancer play to their strengths and avoid weaknesses.

Once you find that you are going in the wrong direction, you should immediately consider reducing losses.

The people and organizations around is it safe to use cbd oil with pharmaceutical drugs us require us cbd oil cancer to be faithful and reliable. Bosses, brands shelf life of cbd oil and even politicians demand that we be loyal, obedient and amount of cbd oil for colon cancer patriotic. Xie Zheng looked at this Amount Of Cbd Oil For Colon Cancer spotless notebook carefully, and James was shining shoes in his mind. It seems for colon cancer that pure kana cbd oil buy he usually maintains his computer very carefully.

5 Tendency. A person s personality tendencies are manifested in different attitudes, experiences and specific behaviors what is cbd oil good for towards things.

Because the expected amount of cbd oil for colon cancer probability is too high, too easy work will affect top 10 cbd oil companies the employee s sense of accomplishment and lose can you bake with cbd oil the intrinsic value of the goal.

Mississippi How To Get Cannabis Oil?

In a few words, it is cancer oil cancer highlighted in an eye catching form, which has the effect of seeing the big with small and struggling amount of cbd oil for colon cancer hard bluegrass hemp oil with light. He said that at the beginning of the recent is cbd oil standardized and is it safe cbd year, the bid was for tight, and when the end of the year was loose, there would be more money

People with this kind of psychology often feel ashamed, doubt for colon their knowledge and abilities, and amount of cbd oil for colon cancer cringe in communication. This is the content hemp oil benefits proper amount of cbd oil of the textbook. Let me tell you the real situation in the market. Xie Zheng was invited to tell the agent how to quote. I will tell you the real situation in the market.

Is it important enough Of course, there is amount of cbd oil for colon cancer no real do you need a prescription for cbd oil in arkansas elf Exist, only you really exists. A person can only cbd oil 500mg have one driving license.

Please note that I am talking about doing my best. Maybe it s not easy to do this in six flights a day.

When you say something like this of cbd oil for cancer out loud, how much does hempworx cbd oil cost the situation amount of cbd oil for colon cancer becomes very interesting I did this because of resistance. Zhuge and holding a beer said, Brother, it s does hemp oil help with pain cbd oil regulations in gloucester ma difficult. At Weihua, we oil are wolves tactics, and we all kill amount people to person customers.

Managers should guide and make proper arrangements nat pathic doctor cbd oil for cancer according to their characteristics grasp the characteristics amount of cbd oil for colon cancer of of oil for their love of new things but the enthusiasm that easily fades, and arrange for them to work amount cbd in a variety of rso cbd oil ways, or arrange for them with several tasks that need to be coffee infused with cbd oil done simultaneously. At the Sunshine Club, he would naturally agree to have amount of cbd oil for colon cancer time. The Sunshine Club is on the second floor of Beijing Wangfujing Hotel.

Such as What do you think Really What about the next What happened And so on. amount of cbd oil cancer 2 cvs cbd oil Don isolate direct cbd oil drops coupon code t be misled by the other party s concealment or verbal skills defects, but try to hear amount of cbd oil for colon cancer the true intentions or substantive problems the other party wants to express. That s true. Some people say he has a cleanliness addiction. Emily once oil how to get cbd oil in missouri helped him carry a laptop bag. He wiped it dr oz cbd oil for diabetes off with a handkerchief when Emily was away.

What Is The Diane Of Cbd For Dogs?

Amount Of Cbd Oil For Colon Cancer Through these defensive methods to regulate amount of cbd oil for colon cancer negative emotions such as sadness, sorrow, pain, hatred, anger, fear, etc.

Finally, it is emphasized that personality is not only behavior and greengardengold cbd oil reviews ideal, but also a dynamic system that best cbd oil for stress and anxiety restricts various activities.

Giannini s visionary spirit made everyone admire him and agreed with cbd oil for acne his decision to get rid of the amount of cbd oil for colon cancer shell.

In modern management, the leader should not only have his personal psychological quality characteristics, but also cbd oil with thc legal by prescription in texas his group psychological quality characteristics. of cbd oil He was expelled of oil colon cancer one month before graduation because he misappropriated money from the student union.

Among the 6 pairs sold Five pairs have cbd oil for colon been golden cbd oil reviews recovered. amount of cbd oil for colon cancer I hope that the buyer of the sixth pair of shoes 7mg cbd oil use for belly bloat will come cbd for cancer to the shoe store to handle the return. Recently I heard that there will be personnel transfers in the headquarters. Don t go of oil for colon cancer now, and observe in Beijing.

This is the result of your amount of cbd oil for colon cancer shenpa trouble, it is cbd oil sprays your own cbd oil disadvantages trouble. The lizard brain is the culprit of shenpa, which is the result of the interaction between the colon general rational world and the strong fear produced by the lizard brain. I, I. Xie Zheng punched the wall with annoyance. Coco said amount of cbd oil for colon cancer that does cbd oil show up on a drug test il Zhang Fan was working in a hotel, but cbd oil review forum he didn t expect that he would be in Wangfujing Hotel, otherwise he would not go there. Dr. Chapman amount of oil for colon cancer said We cannot control our own physiological reactions, but canine squamous cell carcinoma cbd oil we can control our own thoughts and cbd oil like cw behaviors. The thief amount of cbd oil for colon cancer was ashamed and slipped away with his head down. The Zen master watched the thief cannabis cbd oil disappear into the mountains and said with emotion, Poor man I hope I can send him a bright moon to illuminate his way down amount of cbd for cancer cbd oil treatment for pain the mountain.

Americans therefore began to snap up Japanese amount of cbd oil for colon cancer cars with higher fuel saving rates. Although amount of oil Chrysler Motors of the United States ranks first in the auto amount of cbd for industry, hemp oil for cancer it has not been immune from the sales crisis. Since this summer vacation, every why does my cbd oil taste like plastic Thursday, you and your mother of They all hurriedly finished dinner and rushed amount of cbd oil for colon cancer to the community library to amount of cbd oil participate in the activity of amount making a book.

Out of consideration for their own development, people want of to achieve something in a place what strength cbd oil for anxiety reddit where they can be regarded as an indispensable key person Karma, but in order to achieve this goal, amount of cbd oil for colon cancer you must first be able to selflessly give gifts to others so that others can taste the sweetness.

Retreat. Directly avoid or flee from situations or people that make you fear and pain. In bad emotions, a strong excitatory foci is often formed in the human brain. By avoiding related external stimuli, this excitatory foci for can give way to new excitatory foci caused by other stimuli.

The clothing is sold to overseas markets to make money. Here, I call all the institutions or organizations of for that have something to do with the meaning of factory as factories.

They can continue to expand new business areas for the company colon cancer and create new revenue growth points look at those mediocre people, they only know the number to answer the phone and do ordinary work without creativity.

Cannabis and Cannabinoids (PDQ®): Integrative, alternative, and complementary therapies – Health Professional Information [NCI]

This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.

Overview

This cancer information summary provides an overview of the use of Cannabis and its components as a treatment for people with cancer-related symptoms caused by the disease itself or its treatment.

This summary contains the following key information:

  • Cannabis has been used for medicinal purposes for thousands of years.
  • By federal law, the possession of Cannabis is illegal in the United States, except within approved research settings; however, a growing number of states, territories, and the District of Columbia have enacted laws to legalize its medical use.
  • The U.S. Food and Drug Administration has not approved Cannabis as a treatment for cancer or any other medical condition.
  • Chemical components of Cannabis, called cannabinoids, activate specific receptors throughout the body to produce pharmacologic effects, particularly in the central nervous system and the immune system.
  • Commercially available cannabinoids, such as dronabinol and nabilone, are approved drugs for the treatment of cancer-related side effects.
  • Cannabinoids may have benefits in the treatment of cancer-related side effects.

Many of the medical and scientific terms used in this summary are hypertext linked (at first use in each section) to the NCI Dictionary of Cancer Terms, which is oriented toward nonexperts. When a linked term is clicked, a definition will appear in a separate window.

Reference citations in some PDQ cancer information summaries may include links to external websites that are operated by individuals or organizations for the purpose of marketing or advocating the use of specific treatments or products. These reference citations are included for informational purposes only. Their inclusion should not be viewed as an endorsement of the content of the websites, or of any treatment or product, by the PDQ Integrative, Alternative, and Complementary Therapies Editorial Board or the National Cancer Institute.

General Information

Cannabis, also known as marijuana, originated in Central Asia but is grown worldwide today. In the United States, it is a controlled substance and is classified as a Schedule I agent (a drug with a high potential for abuse, and no currently accepted medical use). The Cannabis plant produces a resin containing 21-carbon terpenophenolic compounds called cannabinoids, in addition to other compounds found in plants, such as terpenes and flavonoids. The highest concentration of cannabinoids is found in the female flowers of the plant.[1] Delta-9-tetrahydrocannabinol (THC) is the main psychoactive cannabinoid but over 100 other cannabinoids have been reported to be present in the plant. Cannabidiol (CBD) does not produce the characteristic altered consciousness associated with Cannabis but is felt to have potential therapeutic effectiveness and has recently been approved in the form of the pharmaceutical Epidiolex for the treatment of refractory seizure disorders in children. Other cannabinoids that are being investigated for potential medical benefits include cannabinol (CBN), cannabigerol (CBG), and tetrahydrocannabivarin (THCV), although data from human studies are currently unavailable.

Clinical trials conducted on medicinal Cannabis are limited. The U.S. Food and Drug Administration (FDA) has not approved the use of Cannabis as a treatment for any medical condition, although both isolated THC and CBD pharmaceuticals are licensed and approved. To conduct clinical drug research with botanical Cannabis in the United States, researchers must file an Investigational New Drug (IND) application with the FDA, obtain a Schedule I license from the U.S. Drug Enforcement Administration, and obtain approval from the National Institute on Drug Abuse.

In the 2018 United States Farm Bill, the term hemp is used to describe cultivars of the Cannabis species that contain less than 0.3% THC. Hemp oil or CBD oil are products manufactured from extracts of industrial hemp (i.e., low-THC cannabis cultivars), whereas hemp seed oil is an edible fatty oil that is essentially cannabinoid-free (refer to Table 1). Some products contain other botanical extracts and/or over-the-counter analgesics, and are readily available as oral and topical tinctures or other formulations often advertised for pain management and other purposes. Hemp products containing less than 0.3% of delta-9-THC are not scheduled drugs and could be considered as Farm Bill compliant. Hemp is not a controlled substance; however, CBD is a controlled substance.

Table 1. MedicinalCannabis Products—Guide to Terminology

Name/Material Constituents/Composition
CBD = cannabidiol; THC = tetrahydrocannabinol.
Cannabis species, includingC. sativa Cannabinoids; also terpenoids and flavonoids
• Hemp (aka industrial hemp) Low Δ 9 -THC (<0.3%); high CBD
• Marijuana/marihuana High Δ 9 -THC (>0.3%); low CBD
Nabiximols (trade name: Sativex) Mixture of ethanol extracts ofCannabis species; contains Δ 9 -THC and CBD in a 1:1 ratio
Hemp oil/CBD oil Solution of asolventextract fromCannabis flowers and/or leaves dissolved in an edible oil; typically containing 1%–5% CBD
Hemp seed oil Edible, fatty oil produced fromCannabis seeds; contains no or only traces of cannabinoids
Dronabinol(trade names: Marinol and Syndros) SyntheticΔ 9 -THC
Nabilone(trade names:Cesametand Canemes) Synthetic THCanalog
Cannabidiol (trade name: Epidiolex) Highly purified (>98%), plant-derived CBD

The potential benefits of medicinal Cannabis for people living with cancer include the following:[2]

  • Antiemetic effects.
  • Appetite stimulation.
  • Pain relief.
  • Improved sleep.

Although few relevant surveys of practice patterns exist, it appears that physicians caring for cancer patients in the United States who recommend medicinal Cannabis do so predominantly for symptom management.[3] A growing number of pediatric patients are seeking symptom relief with Cannabis or cannabinoid treatment, although studies are limited.[4] The American Academy of Pediatrics has not endorsed Cannabis and cannabinoid use because of concerns about brain development.

This summary will review the role of Cannabis and the cannabinoids in the treatment of people with cancer and disease-related or treatment-related side effects.

  1. Adams IB, Martin BR: Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (11): 1585-614, 1996.
  2. Abrams DI: Integrating cannabis into clinical cancer care. Curr Oncol 23 (2): S8-S14, 2016.
  3. Doblin RE, Kleiman MA: Marijuana as antiemetic medicine: a survey of oncologists’ experiences and attitudes. J Clin Oncol 9 (7): 1314-9, 1991.
  4. Sallan SE, Cronin C, Zelen M, et al.: Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med 302 (3): 135-8, 1980.

History

Cannabis use for medicinal purposes dates back at least 3,000 years.[1,2,3,4,5] It was introduced into Western medicine in 1839 by W.B. O’Shaughnessy, a surgeon who learned of its medicinal properties while working in India for the British East India Company. Its use was promoted for reported analgesic, sedative, anti-inflammatory, antispasmodic, and anticonvulsant effects.

In 1937, the U.S. Treasury Department introduced the Marihuana Tax Act. This Act imposed a levy of $1 per ounce for medicinal use of Cannabis and $100 per ounce for nonmedical use. Physicians in the United States were the principal opponents of the Act. The American Medical Association (AMA) opposed the Act because physicians were required to pay a special tax for prescribing Cannabis, use special order forms to procure it, and keep special records concerning its professional use. In addition, the AMA believed that objective evidence that Cannabis was harmful was lacking and that passage of the Act would impede further research into its medicinal worth.[6] In 1942, Cannabis was removed from the U.S. Pharmacopoeia because of persistent concerns about its potential to cause harm.[2,3] Recently, there has been renewed interest in Cannabis by the U.S. Pharmacopeia.[7]

In 1951, Congress passed the Boggs Act, which for the first time included Cannabis with narcotic drugs. In 1970, with the passage of the Controlled Substances Act, marijuana was classified by Congress as a Schedule I drug. Drugs in Schedule I are distinguished as having no currently accepted medicinal use in the United States. Other Schedule I substances include heroin, LSD, mescaline, and methaqualone.

Despite its designation as having no medicinal use, Cannabis was distributed by the U.S. government to patients on a case-by-case basis under the Compassionate Use Investigational New Drug program established in 1978. Distribution of Cannabis through this program was closed to new patients in 1992.[1,2,3,4] Although federal law prohibits the use of Cannabis, Figure 1 below shows the states and territories that have legalized Cannabis use for medical purposes. Additional states have legalized only one ingredient in Cannabis, such as cannabidiol (CBD), and are not included in the map. Some medical marijuana laws are broader than others, and there is state-to-state variation in the types of medical conditions for which treatment is allowed.[8]

Figure 1. A map showing the U.S. states and territories that have approved the medical use of Cannabis. Last updated: 11/05/2020

The main psychoactive constituent of Cannabis was identified as delta-9-tetrahydrocannabinol (THC). In 1986, an isomer of synthetic delta-9-THC in sesame oil was licensed and approved for the treatment of chemotherapy -associated nausea and vomiting under the generic name dronabinol. Clinical trials determined that dronabinol was as effective as or better than other antiemetic agents available at the time.[9] Dronabinol was also studied for its ability to stimulate weight gain in patients with AIDS in the late 1980s. Thus, the indications were expanded to include treatment of anorexia associated with human immunodeficiency virus infection in 1992. Clinical trial results showed no statistically significant weight gain, although patients reported an improvement in appetite.[10,11] Another important cannabinoid found in Cannabis is CBD.[12] This is a nonpsychoactive cannabinoid, which is an analog of THC.

In recent decades, the neurobiology of cannabinoids has been analyzed.[13,14,15,16] The first cannabinoid receptor, CB1, was identified in the brain in 1988. A second cannabinoid receptor, CB2, was identified in 1993. The highest expression of CB2 receptors is located on B lymphocytes and natural killer cells, suggesting a possible role in immunity. Endogenous cannabinoids (endocannabinoids) have been identified and appear to have a role in pain modulation, control of movement, feeding behavior, mood, bone growth, inflammation, neuroprotection, and memory.[17]

Nabiximols (Sativex), a Cannabisextract with a 1:1 ratio of THC:CBD, is approved in Canada (under the Notice of Compliance with Conditions) for symptomatic relief of pain in advanced cancer and multiple sclerosis.[18] Nabiximols is an herbal preparation containing a defined quantity of specific cannabinoids formulated for oromucosal spray administration with potential analgesic activity. Nabiximols contains extracts from two Cannabis plant varieties. The extracts mixture is standardized to the concentrations of the psychoactive delta-9-THC and the nonpsychoactive CBD. The preparation also contains other, more minor cannabinoids, flavonoids, and terpenoids.[19] Canada, New Zealand, and most countries in western Europe also approve nabiximols for spasticity of multiple sclerosis, a common symptom that may include muscle stiffness, reduced mobility, and pain, and for which existing therapy is unsatisfactory.

  1. Abel EL: Marihuana, The First Twelve Thousand Years. New York: Plenum Press, 1980. Also available online. Last accessed October 18, 2017.
  2. Joy JE, Watson SJ, Benson JA, eds.: Marijuana and Medicine: Assessing the Science Base. Washington, DC: National Academy Press, 1999. Also available online. Last accessed October 18, 2017.
  3. Mack A, Joy J: Marijuana As Medicine? The Science Beyond the Controversy. Washington, DC: National Academy Press, 2001. Also available online. Last accessed October 18, 2017.
  4. Booth M: Cannabis: A History. New York, NY: St Martin’s Press, 2003.
  5. Russo EB, Jiang HE, Li X, et al.: Phytochemical and genetic analyses of ancient cannabis from Central Asia. J Exp Bot 59 (15): 4171-82, 2008.
  6. Schaffer Library of Drug Policy: The Marihuana Tax Act of 1937: Taxation of Marihuana. Washington, DC: House of Representatives, Committee on Ways and Means, 1937. Available online. Last accessed October 18, 2017.
  7. Sarma ND, Waye A, ElSohly MA, et al.: Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes. J Nat Prod 83 (4): 1334-1351, 2020.
  8. National Academies of Sciences, Engineering, and Medicine: The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press, 2017.
  9. Sallan SE, Zinberg NE, Frei E: Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med 293 (16): 795-7, 1975.
  10. Gorter R, Seefried M, Volberding P: Dronabinol effects on weight in patients with HIV infection. AIDS 6 (1): 127, 1992.
  11. Beal JE, Olson R, Laubenstein L, et al.: Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 10 (2): 89-97, 1995.
  12. Adams R, Hunt M, Clark JH: Structure of cannabidiol: a product isolated from the marihuana extract of Minnesota wild hemp. J Am Chem Soc 62 (1): 196-200, 1940. Also available online. Last accessed October 18, 2017.
  13. Devane WA, Dysarz FA, Johnson MR, et al.: Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34 (5): 605-13, 1988.
  14. Devane WA, Hanus L, Breuer A, et al.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (5090): 1946-9, 1992.
  15. Pertwee RG, Howlett AC, Abood ME, et al.: International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev 62 (4): 588-631, 2010.
  16. Felder CC, Glass M: Cannabinoid receptors and their endogenous agonists. Annu Rev Pharmacol Toxicol 38: 179-200, 1998.
  17. Pacher P, Bátkai S, Kunos G: The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58 (3): 389-462, 2006.
  18. Howard P, Twycross R, Shuster J, et al.: Cannabinoids. J Pain Symptom Manage 46 (1): 142-9, 2013.
  19. Nabiximols. Bethesda, MD: National Center for Biotechnology Information, 2009. Available online. Last accessed January 28, 2020.

Laboratory / Animal / Preclinical Studies

Cannabinoids are a group of 21-carbon–containing terpenophenolic compounds produced uniquely by Cannabis species (e.g., Cannabis sativa L.).[1,2] These plant-derived compounds may be referred to as phytocannabinoids. Although delta-9-tetrahydrocannabinol (THC) is the primary psychoactive ingredient, other known compounds with biologic activity are cannabinol, cannabidiol (CBD), cannabichromene, cannabigerol, tetrahydrocannabivarin, and delta-8-THC. CBD, in particular, is thought to have significant analgesic, anti-inflammatory, and anxiolytic activity without the psychoactive effect (high) of delta-9-THC.

Antitumor Effects

One study in mice and rats suggested that cannabinoids may have a protective effect against the development of certain types of tumors.[3] During this 2-year study, groups of mice and rats were given various doses of THC by gavage. A dose-related decrease in the incidence of hepatic adenoma tumors and hepatocellular carcinoma (HCC) was observed in the mice. Decreased incidences of benign tumors (polyps and adenomas) in other organs (mammary gland, uterus, pituitary, testis, and pancreas) were also noted in the rats. In another study, delta-9-THC, delta-8-THC, and cannabinol were found to inhibit the growth of Lewis lung adenocarcinoma cells in vitro and in vivo.[4] In addition, other tumors have been shown to be sensitive to cannabinoid-induced growth inhibition.[5,6,7,8]

Cannabinoids may cause antitumor effects by various mechanisms, including induction of cell death, inhibition of cell growth, and inhibition of tumor angiogenesis invasion and metastasis.[9,10,11,12] Two reviews summarize the molecular mechanisms of action of cannabinoids as antitumor agents.[13,14] Cannabinoids appear to kill tumor cells but do not affect their nontransformed counterparts and may even protect them from cell death. For example, these compounds have been shown to induce apoptosis in glioma cells in culture and induce regression of glioma tumors in mice and rats, while they protect normal glial cells of astroglial and oligodendroglial lineages from apoptosis mediated by the CB1 receptor.[9]

The effects of delta-9-THC and a synthetic agonist of the CB2 receptor were investigated in HCC.[15] Both agents reduced the viability of HCC cells in vitro and demonstrated antitumor effects in HCC subcutaneous xenografts in nude mice. The investigations documented that the anti-HCC effects are mediated by way of the CB2 receptor. Similar to findings in glioma cells, the cannabinoids were shown to trigger cell death through stimulation of an endoplasmic reticulum stress pathway that activates autophagy and promotes apoptosis. Other investigations have confirmed that CB1 and CB2 receptors may be potential targets in non-small cell lung carcinoma [16] and breast cancer.[17]

An in vitro study of the effect of CBD on programmed cell death in breast cancer cell lines found that CBD induced programmed cell death, independent of the CB1, CB2, or vanilloid receptors. CBD inhibited the survival of both estrogen receptor–positive and estrogen receptor–negative breast cancer cell lines, inducing apoptosis in a concentration-dependent manner while having little effect on nontumorigenic mammary cells.[18] Other studies have also shown the antitumor effect of cannabinoids (i.e., CBD and THC) in preclinical models of breast cancer.[19,20]

CBD has also been demonstrated to exert a chemopreventive effect in a mouse model of colon cancer.[21] In this experimental system, azoxymethane increased premalignant and malignant lesions in the mouse colon. Animals treated with azoxymethane and CBD concurrently were protected from developing premalignant and malignant lesions. In in vitro experiments involving colorectal cancer cell lines, the investigators found that CBD protected DNA from oxidative damage, increased endocannabinoid levels, and reduced cell proliferation. In a subsequent study, the investigators found that the antiproliferative effect of CBD was counteracted by selective CB1 but not CB2 receptor antagonists, suggesting an involvement of CB1 receptors.[22]

Another investigation into the antitumor effects of CBD examined the role of intercellular adhesion molecule-1 (ICAM-1).[12] ICAM-1 expression in tumor cells has been reported to be negatively correlated with cancer metastasis. In lung cancer cell lines, CBD upregulated ICAM-1, leading to decreased cancer cell invasiveness.

In an in vivo model using severe combined immunodeficient mice, subcutaneous tumors were generated by inoculating the animals with cells from human non-small cell lung carcinoma cell lines.[23] Tumor growth was inhibited by 60% in THC-treated mice compared with vehicle-treated control mice. Tumor specimens revealed that THC had antiangiogenic and antiproliferative effects. However, research with immunocompetent murine tumor models has demonstrated immunosuppression and enhanced tumor growth in mice treated with THC.[24,25]

In addition, both plant-derived and endogenous cannabinoids have been studied for anti-inflammatory effects. A mouse study demonstrated that endogenous cannabinoid system signaling is likely to provide intrinsic protection against colonic inflammation.[26] As a result, a hypothesis that phytocannabinoids and endocannabinoids may be useful in the risk reduction and treatment of colorectal cancer has been developed.[27,28,29,30]

CBD may also enhance uptake of cytotoxic drugs into malignant cells. Activation of transient receptor potential vanilloid type 2 (TRPV2) has been shown to inhibit proliferation of human glioblastoma multiforme cells and overcome resistance to the chemotherapy agent carmustine. [31] One study showed that coadministration of THC and CBD over single-agent usage had greater antiproliferative activity in an in vitro study with multiple human glioblastoma multiforme cell lines.[32] In an in vitro model, CBD increased TRPV2 activation and increased uptake of cytotoxic drugs, leading to apoptosis of glioma cells without affecting normal human astrocytes. This suggests that coadministration of CBD with cytotoxic agents may increase drug uptake and potentiate cell death in human glioma cells. Also, CBD together with THC may enhance the antitumor activity of classic chemotherapeutic drugs such as temozolomide in some mouse models of cancer.[13,33] A meta-analysis of 34 in vitro and in vivo studies of cannabinoids in glioma reported that all but one study confirmed that cannabinoids selectively kill tumor cells.[34]

Antiemetic Effects

Preclinical research suggests that emetic circuitry is tonically controlled by endocannabinoids. The antiemetic action of cannabinoids is believed to be mediated via interaction with the 5-hydroxytryptamine 3 (5-HT3) receptor. CB1 receptors and 5-HT3 receptors are colocalized on gamma-aminobutyric acid (GABA)-ergic neurons, where they have opposite effects on GABA release.[35] There also may be direct inhibition of 5-HT3 gated ion currents through non–CB1 receptor pathways. CB1 receptor antagonists have been shown to elicit emesis in the least shrew that is reversed by cannabinoid agonists.[36] The involvement of CB1 receptor in emesis prevention has been shown by the ability of CB1 antagonists to reverse the effects of THC and other synthetic cannabinoid CB1 agonists in suppressing vomiting caused by cisplatin in the house musk shrew and lithium chloride in the least shrew. In the latter model, CBD was also shown to be efficacious.[37,38]

Appetite Stimulation

Many animal studies have previously demonstrated that delta-9-THC and other cannabinoids have a stimulatory effect on appetite and increase food intake. It is believed that the endogenous cannabinoid system may serve as a regulator of feeding behavior. The endogenous cannabinoid anandamide potently enhances appetite in mice.[39] Moreover, CB1 receptors in the hypothalamus may be involved in the motivational or reward aspects of eating.[40]

Understanding the mechanism of cannabinoid-induced analgesia has been increased through the study of cannabinoid receptors, endocannabinoids, and synthetic agonists and antagonists. Cannabinoids produce analgesia through supraspinal, spinal, and peripheral modes of action, acting on both ascending and descending pain pathways.[41] The CB1 receptor is found in both the central nervous system (CNS) and in peripheral nerve terminals. Similar to opioid receptors, increased levels of the CB1 receptor are found in regions of the brain that regulate nociceptive processing.[42] CB2 receptors, located predominantly in peripheral tissue, exist at very low levels in the CNS. With the development of receptor-specific antagonists, additional information about the roles of the receptors and endogenous cannabinoids in the modulation of pain has been obtained.[43,44]

Cannabinoids may also contribute to pain modulation through an anti-inflammatory mechanism; a CB2 effect with cannabinoids acting on mast cell receptors to attenuate the release of inflammatory agents, such as histamine and serotonin, and on keratinocytes to enhance the release of analgesic opioids has been described.[45,46,47] One study reported that the efficacy of synthetic CB1- and CB2-receptor agonists were comparable with the efficacy of morphine in a murine model of tumor pain.[48]

Cannabinoids have been shown to prevent chemotherapy-induced neuropathy in animal models exposed to paclitaxel, vincristine, or cisplatin.[49,50,51]

Anxiety and Sleep

The endocannabinoid system is believed to be centrally involved in the regulation of mood and the extinction of aversive memories. Animal studies have shown CBD to have anxiolytic properties. It was shown in rats that these anxiolytic properties are mediated through unknown mechanisms.[52] Anxiolytic effects of CBD have been shown in several animal models.[53,54]

The endocannabinoid system has also been shown to play a key role in the modulation of the sleep-waking cycle in rats.[55,56]

  1. Adams IB, Martin BR: Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (11): 1585-614, 1996.
  2. Grotenhermen F, Russo E, eds.: Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential. Binghamton, NY: The Haworth Press, 2002.
  3. National Toxicology Program: NTP toxicology and carcinogenesis studies of 1-trans-delta(9)-tetrahydrocannabinol (CAS No. 1972-08-3) in F344 rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 446: 1-317, 1996.
  4. Bifulco M, Laezza C, Pisanti S, et al.: Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol 148 (2): 123-35, 2006.
  5. Sánchez C, de Ceballos ML, Gomez del Pulgar T, et al.: Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61 (15): 5784-9, 2001.
  6. McKallip RJ, Lombard C, Fisher M, et al.: Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100 (2): 627-34, 2002.
  7. Casanova ML, Blázquez C, Martínez-Palacio J, et al.: Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111 (1): 43-50, 2003.
  8. Blázquez C, González-Feria L, Alvarez L, et al.: Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res 64 (16): 5617-23, 2004.
  9. Guzmán M: Cannabinoids: potential anticancer agents. Nat Rev Cancer 3 (10): 745-55, 2003.
  10. Blázquez C, Casanova ML, Planas A, et al.: Inhibition of tumor angiogenesis by cannabinoids. FASEB J 17 (3): 529-31, 2003.
  11. Vaccani A, Massi P, Colombo A, et al.: Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br J Pharmacol 144 (8): 1032-6, 2005.
  12. Ramer R, Bublitz K, Freimuth N, et al.: Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J 26 (4): 1535-48, 2012.
  13. Velasco G, Sánchez C, Guzmán M: Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 12 (6): 436-44, 2012.
  14. Cridge BJ, Rosengren RJ: Critical appraisal of the potential use of cannabinoids in cancer management. Cancer Manag Res 5: 301-13, 2013.
  15. Vara D, Salazar M, Olea-Herrero N, et al.: Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ 18 (7): 1099-111, 2011.
  16. Preet A, Qamri Z, Nasser MW, et al.: Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev Res (Phila) 4 (1): 65-75, 2011.
  17. Nasser MW, Qamri Z, Deol YS, et al.: Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. PLoS One 6 (9): e23901, 2011.
  18. Shrivastava A, Kuzontkoski PM, Groopman JE, et al.: Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol Cancer Ther 10 (7): 1161-72, 2011.
  19. Caffarel MM, Andradas C, Mira E, et al.: Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol Cancer 9: 196, 2010.
  20. McAllister SD, Murase R, Christian RT, et al.: Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat 129 (1): 37-47, 2011.
  21. Aviello G, Romano B, Borrelli F, et al.: Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med (Berl) 90 (8): 925-34, 2012.
  22. Romano B, Borrelli F, Pagano E, et al.: Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. Phytomedicine 21 (5): 631-9, 2014.
  23. Preet A, Ganju RK, Groopman JE: Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene 27 (3): 339-46, 2008.
  24. Zhu LX, Sharma S, Stolina M, et al.: Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol 165 (1): 373-80, 2000.
  25. McKallip RJ, Nagarkatti M, Nagarkatti PS: Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol 174 (6): 3281-9, 2005.
  26. Massa F, Marsicano G, Hermann H, et al.: The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 113 (8): 1202-9, 2004.
  27. Patsos HA, Hicks DJ, Greenhough A, et al.: Cannabinoids and cancer: potential for colorectal cancer therapy. Biochem Soc Trans 33 (Pt 4): 712-4, 2005.
  28. Liu WM, Fowler DW, Dalgleish AG: Cannabis-derived substances in cancer therapy–an emerging anti-inflammatory role for the cannabinoids. Curr Clin Pharmacol 5 (4): 281-7, 2010.
  29. Malfitano AM, Ciaglia E, Gangemi G, et al.: Update on the endocannabinoid system as an anticancer target. Expert Opin Ther Targets 15 (3): 297-308, 2011.
  30. Sarfaraz S, Adhami VM, Syed DN, et al.: Cannabinoids for cancer treatment: progress and promise. Cancer Res 68 (2): 339-42, 2008.
  31. Nabissi M, Morelli MB, Santoni M, et al.: Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. Carcinogenesis 34 (1): 48-57, 2013.
  32. Marcu JP, Christian RT, Lau D, et al.: Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Mol Cancer Ther 9 (1): 180-9, 2010.
  33. Torres S, Lorente M, Rodríguez-Fornés F, et al.: A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol Cancer Ther 10 (1): 90-103, 2011.
  34. Rocha FC, Dos Santos Júnior JG, Stefano SC, et al.: Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas. J Neurooncol 116 (1): 11-24, 2014.
  35. Pacher P, Bátkai S, Kunos G: The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58 (3): 389-462, 2006.
  36. Darmani NA: Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A. Neuropsychopharmacology 24 (2): 198-203, 2001.
  37. Darmani NA: Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew. Pharmacol Biochem Behav 69 (1-2): 239-49, 2001 May-Jun.
  38. Parker LA, Kwiatkowska M, Burton P, et al.: Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology (Berl) 171 (2): 156-61, 2004.
  39. Mechoulam R, Berry EM, Avraham Y, et al.: Endocannabinoids, feeding and suckling–from our perspective. Int J Obes (Lond) 30 (Suppl 1): S24-8, 2006.
  40. Fride E, Bregman T, Kirkham TC: Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. Exp Biol Med (Maywood) 230 (4): 225-34, 2005.
  41. Baker D, Pryce G, Giovannoni G, et al.: The therapeutic potential of cannabis. Lancet Neurol 2 (5): 291-8, 2003.
  42. Walker JM, Hohmann AG, Martin WJ, et al.: The neurobiology of cannabinoid analgesia. Life Sci 65 (6-7): 665-73, 1999.
  43. Meng ID, Manning BH, Martin WJ, et al.: An analgesia circuit activated by cannabinoids. Nature 395 (6700): 381-3, 1998.
  44. Walker JM, Huang SM, Strangman NM, et al.: Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci U S A 96 (21): 12198-203, 1999.
  45. Facci L, Dal Toso R, Romanello S, et al.: Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A 92 (8): 3376-80, 1995.
  46. Ibrahim MM, Porreca F, Lai J, et al.: CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A 102 (8): 3093-8, 2005.
  47. Richardson JD, Kilo S, Hargreaves KM: Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75 (1): 111-9, 1998.
  48. Khasabova IA, Gielissen J, Chandiramani A, et al.: CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain. Behav Pharmacol 22 (5-6): 607-16, 2011.
  49. Ward SJ, McAllister SD, Kawamura R, et al.: Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy. Br J Pharmacol 171 (3): 636-45, 2014.
  50. Rahn EJ, Makriyannis A, Hohmann AG: Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Br J Pharmacol 152 (5): 765-77, 2007.
  51. Khasabova IA, Khasabov S, Paz J, et al.: Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. J Neurosci 32 (20): 7091-101, 2012.
  52. Campos AC, Guimarães FS: Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl) 199 (2): 223-30, 2008.
  53. Crippa JA, Zuardi AW, Hallak JE: [Therapeutical use of the cannabinoids in psychiatry]. Rev Bras Psiquiatr 32 (Suppl 1): S56-66, 2010.
  54. Guimarães FS, Chiaretti TM, Graeff FG, et al.: Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berl) 100 (4): 558-9, 1990.
  55. Méndez-Díaz M, Caynas-Rojas S, Arteaga Santacruz V, et al.: Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats. Pharmacol Biochem Behav 107: 29-35, 2013.
  56. Pava MJ, den Hartog CR, Blanco-Centurion C, et al.: Endocannabinoid modulation of cortical up-states and NREM sleep. PLoS One 9 (2): e88672, 2014.

Human / Clinical Studies

CannabisPharmacology

When oral Cannabis is ingested, there is a low (6%–20%) and variable oral bioavailability.[1,2] Peak plasma concentrations of delta-9-tetrahydrocannabinol (THC) occur after 1 to 6 hours and remain elevated with a terminal half-life of 20 to 30 hours. Taken by mouth, delta-9-THC is initially metabolized in the liver to 11-OH-THC, a potent psychoactive metabolite. Inhaled cannabinoids are rapidly absorbed into the bloodstream with a peak concentration in 2 to 10 minutes, declining rapidly for a period of 30 minutes and with less generation of the psychoactive 11-OH metabolite.

Cannabinoids are known to interact with the hepatic cytochrome P450 enzyme system.[3,4] In one study, 24 cancer patients were treated with intravenous irinotecan (600 mg, n = 12) or docetaxel (180 mg, n = 12), followed 3 weeks later by the same drugs concomitant with medicinal Cannabis taken in the form of an herbal tea for 15 consecutive days, starting 12 days before the second treatment.[4] The administration of Cannabis did not significantly influence exposure to and clearance of irinotecan or docetaxel, although the herbal tea route of administration may not reproduce the effects of inhalation or oral ingestion of fat-soluble cannabinoids.

Highly concentrated THC or cannabidiol (CBD) oil extracts are being illegally promoted as potential cancer cures.[5] These oils have not been evaluated in any clinical trials for anticancer activity or safety. Because CBD is a potential inhibitor of certain cytochrome P450 enzymes, highly concentrated CBD oils used concurrently with conventional therapies that are metabolized by these enzymes could potentially increase toxicity or decrease the effectiveness of these therapies.[6,7]

Cancer Risk

A number of studies have yielded conflicting evidence regarding the risks of various cancers associated with Cannabis smoking.

A pooled analysis of three case-cohort studies of men in northwestern Africa (430 cases and 778 controls) showed a significantly increased risk of lung cancer among tobacco smokers who also inhaled Cannabis.[8]

A large, retrospective cohort study of 64,855 men aged 15 to 49 years from the United States found that Cannabis use was not associated with tobacco-related cancers and a number of other common malignancies. However, the study did find that, among nonsmokers of tobacco, ever having used Cannabis was associated with an increased risk of prostate cancer.[9]

A population-based case-control study of 611 lung cancer patients revealed that chronic low Cannabis exposure was not associated with an increased risk of lung cancer or other upper aerodigestive tract cancers and found no positive associations with any cancer type (oral, pharyngeal, laryngeal, lung, or esophagus) when adjusting for several confounders, including cigarette smoking.[10]

A systematic review assessing 19 studies that evaluated premalignant or malignant lung lesions in persons 18 years or older who inhaled Cannabis concluded that observational studies failed to demonstrate statistically significant associations between Cannabis inhalation and lung cancer after adjusting for tobacco use.[11] In the review of the published meta-analyses, the National Academies of Sciences, Engineering, and Medicine (NASEM) report concluded that there was moderate evidence of no statistical association between Cannabis smoking and the incidence of lung cancer.[12]

Epidemiologic studies examining one association of Cannabis use with head and neck squamous cell carcinomas have also been inconsistent in their findings. A pooled analysis of nine case-control studies from the U.S./Latin American International Head and Neck Cancer Epidemiology (INHANCE) Consortium included information from 1,921 oropharyngeal cases, 356 tongue cases, and 7,639 controls. Compared with those who never smoked Cannabis, Cannabis smokers had an elevated risk of oropharyngeal cancers and a reduced risk of tongue cancer. These study results both reflect the inconsistent effects of cannabinoids on cancer incidence noted in previous studies and suggest that more work needs to be done to understand the potential role of human papillomavirus infection.[13] A systematic review and meta-analysis of nine case-control studies involving 13,931 participants also concluded that there was insufficient evidence to support or refute a positive or negative association between Cannabis smoking and the incidence of head and neck cancers.[14]

With a hypothesis that chronic marijuana use produces adverse effects on the human endocrine and reproductive systems, the association between Cannabis use and incidence of testicular germ cell tumors (TGCTs) has been examined.[15,16,17] Three population-based case-control studies reported an association between Cannabis use and elevated risk of TGCTs, especially nonseminoma or mixed-histology tumors.[15,16,17] However, the sample sizes in these studies were inadequate to address Cannabisdose by addressing associations with respect to recency, frequency, and duration of use. In a study of 49,343 Swedish men aged 19 to 21 years enrolled in the military between 1969 and 1970, participants were asked once at the time of conscription about their use of Cannabis and were followed up for 42 years.[18] This study found no evidence of a significant relation between “ever” Cannabis use and the development of testicular cancer, but did find that “heavy” Cannabis use (more than 50 times in a lifetime) was associated with a 2.5-fold increased risk. Limitations of the study were that it relied on indirect assessment of Cannabis use; and no information was collected on Cannabis use after the conscription-assessment period or on whether the testicular cancers were seminoma or nonseminoma subtypes. These reports established the need for larger, well-powered, prospective studies, especially studies evaluating the role of endocannabinoid signaling and cannabinoid receptors in TGCTs.

An analysis of 84,170 participants in the California Men’s Health Study was performed to investigate the association between Cannabis use and the incidence of bladder cancer. During 16 years of follow-up, 89 Cannabis users (0.3%) developed bladder cancer compared with 190 (0.4%) of the men who did not report Cannabis use (P < .001). After adjusting for age, race, ethnicity, and body mass index, Cannabis use was associated with a 45% reduction in bladder cancer incidence (hazard ratio, 0.55; 95% confidence interval (CI), 0.33–1.00).[19]

A comprehensive Health Canada monograph on marijuana concluded that while there are many cellular and molecular studies that provide strong evidence that inhaled marijuana is carcinogenic, the epidemiologic evidence of a link between marijuana use and cancer is still inconclusive.[20]

Patterns ofCannabisUse Among Cancer Patients

A cross-sectional survey of cancer patients seen at the Seattle Cancer Care Alliance was conducted over a 6-week period between 2015 and 2016.[21] In Washington State, Cannabis was legalized for medicinal use in 1998 and for recreational use in 2012. Of the 2,737 possible participants, 936 (34%) completed the anonymous questionnaire. Twenty-four percent of patients considered themselves active Cannabis users. Similar numbers of patients inhaled (70%) or used edibles (70%), with dual use (40%) being common. Non–mutually exclusive reasons for Cannabis use were physical symptoms (75%), neuropsychiatric symptoms (63%), recreational use/enjoyment (35%), and treatment of cancer (26%). The physical symptoms most commonly cited were pain, nausea, and loss of appetite. The majority of patients (74%) stated that they would prefer to obtain information about Cannabis from their cancer team, but less than 15% reported receiving information from their cancer physician or nurse.

Data from 2,970 Israeli cancer patients who used government-issued Cannabis were collected over a 6-month period to assess for improvement in baseline symptoms.[22] The most improved symptoms from baseline include the following:

  • Nausea and vomiting (91.0%).
  • Sleep disorders (87.5%).
  • Restlessness (87.5%).
  • Anxiety and depression (84.2%).
  • Pruritus (82.1%).
  • Headaches (81.4%).

Before treatment initiation, 52.9% of patients reported pain scores in the 8 to 10 range, while only 4.6% of patients reported this intensity at the 6-month assessment time point. It is difficult to assess from the observational data if the improvements were caused by the Cannabis or the cancer treatment.[22] Similarly, a study of a subset of cancer patients in the Minnesota medical Cannabis program explored changes in the severity of eight symptoms (i.e., anxiety, appetite loss, depression, disturbed sleep, fatigue, nausea, pain, and vomiting) experienced by these patients.[23]. Significant symptomatic improvements were noted (38.4%–56.2%) in patients with each symptom. Because of the observational and uncontrolled nature of this study, the findings are not generalizable, but as the authors suggested, may be useful in designing more rigorous research studies in the future.

A retrospective study from Israel of 50 pediatric oncology patients who were prescribed medicinal Cannabis over an 8-year period reported that the most common indications include the following:[24]

  • Nausea and vomiting.
  • Depressed mood.
  • Sleep disturbances.
  • Poor appetite and weight loss.
  • Pain.

Most of the patients (N = 30) received Cannabis in the form of oral oil drops, with some of the older children inhaling vaporized Cannabis or combining inhalation with oral oils. Structured interviews with the parents, and their child when appropriate, revealed that 40 participants (80%) reported a high level of general satisfaction with the use of Cannabis with infrequent short-term side effects.[24]

Cancer Treatment

No ongoing clinical trials of Cannabis as a treatment for cancer in humans were identified in a PubMed search. The only published trial of any cannabinoid in patients with cancer is a small pilot study of intratumoral injection of delta-9-THC in patients with recurrent glioblastoma multiforme, which demonstrated no significant clinical benefit.[25,26] In a trial (NCT02255292) conducted in Israel, oral CBD was investigated as a single salvage agent for recurrent solid tumors. The study was projected to be completed in 2015; however, no results have been published. A small exploratory phase II study (GWCA1208 Part A [NCT01812603]) was conducted in the United Kingdom that used nabiximols, a 1:1 ratio of THC:CBD in a Cannabis-based medicinal extract oromucosal spray, in conjunction with temozolomide in treating patients with recurrent glioblastoma multiforme. The study enrolled 21 patients. Final results have not been published.

In a 2016 consecutive case series study, nine patients with varying stages of brain tumors, including six with glioblastoma multiforme, received CBD 200 mg twice daily in addition to surgical excision and chemoradiation.[27][Level of evidence: 3iiiA] The authors reported that all but one of the cohort remained alive at the time of publication. However, the heterogeneity of the brain tumor patients probably contributed to the findings.

Another Israeli group postulated that the anti-inflammatory and immunosuppressive effects of CBD might make it a valuable adjunct in the treatment of acute graft-versus-host disease (GVHD) in patients who have undergone allogeneic hematopoietic stem cell transplantation. The authors investigated CBD 300 mg/d in addition to standard GVHD prophylaxis in 48 adult patients who had undergone transplantation predominantly for acute leukemia or myelodysplastic syndrome (NCT01385124 and NCT01596075).[28] The combination of CBD with standard GVHD prophylaxis was found to be safe. Compared with 101 historical controls treated with standard prophylaxis, patients who received CBD appeared to have a lower incidence of grade II to grade IV GVHD, suggesting that a randomized controlled trial (RCT) is warranted.

Clinical data regarding Cannabis as an anticancer agent in pediatric use is limited to a few case reports.[29,30]

Antiemetic Effect

Cannabinoids

Despite advances in pharmacologic and nonpharmacologic management, nausea and vomiting (N/V) remain distressing side effects for cancer patients and their families. Dronabinol, a synthetically produced delta-9-THC, was approved in the United States in 1986 as an antiemetic to be used in cancer chemotherapy. Nabilone, a synthetic derivative of delta-9-THC, was first approved in Canada in 1982 and is now also available in the United States.[31] Both dronabinol and nabilone have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of N/V associated with cancer chemotherapy in patients who have failed to respond to conventional antiemetic therapy. Numerous clinical trials and meta-analyses have shown that dronabinol and nabilone are effective in the treatment of N/V induced by chemotherapy.[32,33,34,35] The National Comprehensive Cancer Network Guidelines recommend cannabinoids as breakthrough treatment for chemotherapy-related N/V.[36] The American Society for Clinical Oncology (ASCO) antiemetic guidelines updated in 2017 recommends that the FDA-approved cannabinoids, dronabinol or nabilone, be used to treat N/V that is resistant to standard antiemetic therapies.[37]

One systematic review studied 30 randomized comparisons of delta-9-THC preparations with placebo or other antiemetics from which data on efficacy and harm were available.[38] Oral nabilone, oral dronabinol, and intramuscular levonantradol (a synthetic analog of dronabinol) were tested. Inhaled Cannabis trials were not included. Among all 1,366 patients included in the review, cannabinoids were found to be more effective than the conventional antiemetics prochlorperazine, metoclopramide, chlorpromazine, thiethylperazine, haloperidol, domperidone, and alizapride. Cannabinoids, however, were not more effective for patients receiving very low or very high emetogenic chemotherapy. Side effects included a feeling of being high, euphoria, sedation or drowsiness, dizziness, dysphoria or depression, hallucinations, paranoia, and hypotension.[38]

Another analysis of 15 controlled studies compared nabilone with placebo or available antiemetic drugs.[39] Among 600 cancer patients, nabilone was found to be superior to prochlorperazine, domperidone, and alizapride, with nabilone favored for continuous use.

A Cochrane meta-analysis of 23 RCTs reviewed studies conducted between 1975 and 1991 that investigated dronabinol or nabilone, either as monotherapy or as an adjunct to the conventional dopamine antagonists that were the standard antiemetics at that time.[40] The chemotherapy regimens involved drugs with low, moderate, or high emetic potential. The meta-analysis graded the quality of evidence as low for most outcomes. The review concluded that individuals were more likely to report complete absence of N/V when they received cannabinoids compared with placebo, although they were more likely to withdraw from the study because of an adverse event. Individuals reported a higher preference for cannabinoids than placebo or prochlorperazine. There was no difference in the antiemetic effect of cannabinoids when compared with prochlorperazine. The authors concluded that Cannabis-based medications may be useful for treating refractory chemotherapy-induced N/V; however, they cautioned that their assessment may change with the availability of newer antiemetic regimens.

At least 50% of patients who receive moderately emetogenic chemotherapy may experience delayed chemotherapy-induced N/V. Although selective neurokinin 1 antagonists that inhibit substance P have been approved for delayed N/V, a study was conducted before their availability to assess dronabinol, ondansetron, or their combination in preventing delayed-onset chemotherapy-induced N/V.[41] Ondansetron, a serotonin 5-hydroxytryptamine 3 (5-HT3) receptor antagonist, is one of the mainstay agents in the current antiemetic armamentarium. In this trial, the primary objective was to assess the response 2 to 5 days after moderately to severely emetogenic chemotherapy. Sixty-one patients were analyzed for efficacy. The total response—a composite endpoint—including nausea intensity, vomiting/retching, and use of rescue medications, was similar with dronabinol (54%), ondansetron (58%), and combination therapy (47%) when compared with placebo (20%). Nausea absence was greater in the active treatment groups (dronabinol 71%, ondansetron 64%, combination therapy 53%) when compared with placebo (15%; P < .05 vs. placebo for all). Occurrence rates for nausea intensity and vomiting/retching episodes were the lowest in patients treated with dronabinol, suggesting that dronabinol compares favorably with ondansetron in this situation where a substance P inhibitor would currently be the drug of choice.

(Refer to the Cannabis section in the PDQ summary on Nausea and Vomiting Related to Cancer Treatment for more information.)

Three trials have evaluated the efficacy of inhaled Cannabis in chemotherapy-induced N/V.[42,43,44,45] In two of the studies, inhaled Cannabis was made available only after dronabinol failure. In the first trial, no antiemetic effect was achieved with marijuana in patients receiving cyclophosphamide or doxorubicin,[42] but in the second trial, a statistically significant superior antiemetic effect of inhaled Cannabis versus placebo was found among patients receiving high-dose methotrexate.[43] The third trial was a randomized, double-blind, placebo-controlled, crossover trial involving 20 adults in which both inhaled marijuana and oral THC were evaluated. One-quarter of the patients reported a favorable antiemetic response to the cannabinoid therapies. This latter study was reported in abstract form in 1984. A full report, detailing the methods and outcomes apparently has not been published, which limits a thorough interpretation of the significance of these findings.[44]

Newer antiemetics (e.g., 5-HT3 receptor antagonists) have not been directly compared with Cannabis or cannabinoids in cancer patients. However, the Cannabis-extract oromucosal spray, nabiximols, formulated with 1:1 THC:CBD was shown in a small pilot randomized, placebo-controlled, double-blinded clinical trial in Spain to treat chemotherapy-related N/V.[46][Level of evidence: 1iC]

ASCO antiemetic guidelines updated in 2017 state that evidence remains insufficient to recommend medical marijuana for either the prevention or treatment of N/V in patients with cancer who receive chemotherapy or radiation therapy.[37]

Appetite Stimulation

Anorexia, early satiety, weight loss, and cachexia are problems experienced by cancer patients. Such patients are faced not only with the disfigurement associated with wasting but also with an inability to engage in the social interaction of meals.

Cannabinoids

Four controlled trials have assessed the effect of oral THC on measures of appetite, food appreciation, calorie intake, and weight loss in patients with advanced malignancies. Three relatively small, placebo-controlled trials (N = 52; N = 46; N = 65) each found that oral THC produced improvements in one or more of these outcomes.[47,48,49] The one study that used an active control evaluated the efficacy of dronabinol alone or with megestrol acetate compared with that of megestrol acetate alone for managing cancer-associated anorexia.[50] In this randomized, double-blind study of 469 adults with advanced cancer and weight loss, patients received 2.5 mg of oral THC twice daily, 800 mg of oral megestrol daily, or both. Appetite increased by 75% in the megestrol group and weight increased by 11%, compared with a 49% increase in appetite and a 3% increase in weight in the oral THC group after 8 to 11 weeks of treatment. The between-group differences were statistically significant in favor of megestrol acetate. Furthermore, the combined therapy did not offer additional benefits beyond those provided by megestrol acetate alone. The authors concluded that dronabinol did little to promote appetite or weight gain in advanced cancer patients compared with megestrol acetate.

In trials conducted in the 1980s that involved healthy control subjects, inhaling Cannabis led to an increase in caloric intake, mainly in the form of between-meal snacks, with increased intakes of fatty and sweet foods.[51,52]

Despite patients’ great interest in oral preparations of Cannabis to improve appetite, there is only one trial of Cannabis extract used for appetite stimulation. In a RCT, researchers compared the safety and effectiveness of orally administered Cannabis extract (2.5 mg THC and 1 mg CBD), THC (2.5 mg), or placebo for the treatment of cancer-related anorexia-cachexia in 243 patients with advanced cancer who received treatment twice daily for 6 weeks. Results demonstrated that although these agents were well tolerated by these patients, no differences were observed in patient appetite or quality of life among the three groups at this dose level and duration of intervention.[53]

No published studies have explored the effect of inhaled Cannabis on appetite in cancer patients.

Cannabinoids

Pain management improves a patient’s quality of life throughout all stages of cancer. Through the study of cannabinoid receptors, endocannabinoids, and synthetic agonists and antagonists, the mechanisms of cannabinoid-induced analgesia have been analyzed.[54][Level of evidence:1iC] The CB1 receptor is found in the central nervous system (CNS) and in peripheral nerve terminals.[55] CB2 receptors are located mainly in peripheral tissue and are expressed in only low amounts in the CNS. Whereas only CB1 agonists exert analgesic activity in the CNS, both CB1 and CB2 agonists have analgesic activity in peripheral tissue.[56,57]

Cancer pain results from inflammation, invasion of bone or other pain-sensitive structures, or nerve injury. When cancer pain is severe and persistent, it is often resistant to treatment with opioids.

Two studies examined the effects of oral delta-9-THC on cancer pain. The first, a double-blind, placebo-controlled study involving ten patients, measured both pain intensity and pain relief.[58] It was reported that 15 mg and 20 mg doses of the cannabinoid delta-9-THC were associated with substantial analgesic effects, with antiemetic effects and appetite stimulation.

In a follow-up, single-dose study involving 36 patients, it was reported that 10 mg doses of delta-9-THC produced analgesic effects during a 7-hour observation period that were comparable to 60 mg doses of codeine, and 20 mg doses of delta-9-THC induced effects equivalent to 120 mg doses of codeine.[59] Higher doses of THC were found to be more sedating than codeine.

Another study examined the effects of a plant extract with controlled cannabinoid content in an oromucosal spray. In a multicenter, double-blind, placebo-controlled study, the THC:CBD nabiximols extract and THC extract alone were compared in the analgesic management of patients with advanced cancer and with moderate-to-severe cancer-related pain. Patients were assigned to one of three treatment groups: THC:CBD extract, THC extract, or placebo. The researchers concluded that the THC:CBD extract was efficacious for pain relief in advanced cancer patients whose pain was not fully relieved by strong opioids.[60] In a randomized, placebo-controlled, graded-dose trial, opioid-treated cancer patients with poorly controlled chronic pain demonstrated significantly better control of pain and sleep disruption with THC:CBD oromucosal spray at lower doses (1–4 and 6–10 sprays/d), compared with placebo. Adverse events were dose related, with only the high-dose group (11–16 sprays/d) comparing unfavorably with the placebo arm. These studies provide promising evidence of an adjuvant analgesic effect of THC:CBD in this opioid-refractory patient population and may provide an opportunity to address this significant clinical challenge.[61] An open-label extension study of 43 patients who had participated in the randomized trial found that some patients continued to obtain relief of their cancer-related pain with long-term use of the THC:CBD oromucosal spray without increasing their dose of the spray or the dose of their other analgesics.[62]

An observational study assessed the effectiveness of nabilone in advanced cancer patients who were experiencing pain and other symptoms (anorexia, depression, and anxiety). The researchers reported that patients who used nabilone experienced improved management of pain, nausea, anxiety, and distress when compared with untreated patients. Nabilone was also associated with a decreased use of opioids, nonsteroidal anti-inflammatory drugs, tricyclic antidepressants, gabapentin, dexamethasone, metoclopramide, and ondansetron.[63]

Animal studies have suggested a synergistic analgesic effect when cannabinoids are combined with opioids. The results from one pharmacokinetic interaction study have been reported. In this study, 21 patients with chronic pain were administered vaporized Cannabis along with sustained-release morphine or oxycodone for 5 days.[64] The patients who received vaporized Cannabis and sustained-release morphine had a statistically significant decrease in their mean pain score over the 5-day period; those who received vaporized Cannabis and oxycodone did not. These findings should be verified by further studies before recommendations favoring such an approach are warranted in general clinical practice.

Neuropathic pain is a symptom cancer patients may experience, especially if treated with platinum-based chemotherapy or taxanes. Two RCTs of inhaled Cannabis in patients with peripheral neuropathy or neuropathic pain of various etiologies found that pain was reduced in patients who received inhaled Cannabis, compared with those who received placebo.[65,66] Additional trials of inhaled Cannabis have also demonstrated the benefit of Cannabis over placebo in HIV-associated neuropathic pain.[67]

A randomized, placebo-controlled, crossover, pilot study of nabiximols in 16 patients with chemotherapy-induced neuropathic pain showed no significant difference between the treatment and placebo groups. A responder analysis, however, demonstrated that five patients reported a reduction in their pain of at least 2 points on an 11-point scale, suggesting that a larger follow-up study may be warranted.[68]

Anxiety and Sleep

Cannabinoids

In a small pilot study of analgesia involving ten patients with cancer pain, secondary measures showed that 15 mg and 20 mg doses of the cannabinoid delta-9-THC were associated with anxiolytic effects.[58][Level of evidence: 1iC]

A small placebo-controlled study of dronabinol in cancer patients with altered chemosensory perception also noted increased quality of sleep and relaxation in THC-treated patients.[48][Level of evidence: 1iC]

Patients often experience mood elevation after exposure to Cannabis, depending on their previous experience. In a five-patient case series of inhaled Cannabis that examined analgesic effects in chronic pain, it was reported that patients who self-administered Cannabis had improved mood, improved sense of well-being, and less anxiety.[69]

Another common effect of Cannabis is sleepiness. A small placebo-controlled study of dronabinol in cancer patients with altered chemosensory perception also noted increased quality of sleep and relaxation in THC-treated patients.[48]

Seventy-four patients with newly diagnosed head and neck cancer self-described as current Cannabis users were matched to 74 nonusers in a Canadian study investigating quality of life using the EuroQol-5D and Edmonton Symptom Assessment System instruments.[70]Cannabis users had significantly lower scores in the anxiety/depression (difference, 0.74; 95% CI, 0.557–0.930) and pain/discomfort (difference, 0.29; 95% CI, 0.037–1.541) domains. Cannabis users were also less tired, had more appetite, and better general well-being.

Clinical Studies ofCannabisand Cannabinoids

Table 2. Clinical Studies ofCannabis a

Reference Citation Type of Study Condition Treated No. of Patients: Enrolled; Treated; Placebo or No Treatment Control b Strongest Benefit Reported c Concurrent TherapyUsed (Yes/No/ Unknown) d Level of Evidence Score e
5-HT3 = 5-hydroxytryptamine 3; CINV = chemotherapy-induced nausea and vomiting; RCT = randomized controlled trial; N/V = nausea and vomiting.
a Refer to text and theNCI Dictionary of Cancer Termsfor additional information and definition of terms.
b Number of patients treated plus number of patient controls may not equal number of patients enrolled; number of patients enrolled equals number of patients initially recruited/considered by the researchers who conducted a study; number of patients treated equals number of enrolled patients who were given the treatment being studied AND for whom results were reported.
c Strongest evidence reported that the treatment under study has activity or otherwise improves the well-being of cancer patients.
d Concurrent therapy for symptoms treated (not cancer).
e For information aboutlevels of evidenceanalysis and an explanation of the level of evidence scores, refer to Levels of Evidence for Human Studies of Integrative, Alternative, and Complementary Therapies.
[42] RCT CINV 8; 8; None None No 1iC
[43] RCT CINV 15; 15; None Decreased N/V No 1iiC
[46] Pilot RCT CINV 16; 7; 9 Decreased delayed N/V 5-HT3 receptor antagonists 1iC
[64] Nonrandomized trial Chronic pain 21;10 (morphine), 11 (oxycodone); None Decreased pain Yes, morphine, oxycodone 2C
[70] Prospective cohort study Anxiety, pain, depression, loss of appetite 148; 74; 74 Decreased pain, anxiety, depression, increased appetite Unknown 2C
Table 3. Clinical Studies of Cannabinoids a

Reference Citation Type of Study Condition Treated No. of Patients: Enrolled; Treated; Placebo or No Treatment Control b Strongest Benefit Reported c Concurrent Therapy Used (Yes/No/ Unknown) d Level of Evidence Score e
CBD = cannabidiol; No. = number; NSAIDs = nonsteroidal anti-inflammatory drugs; QoL =quality of life; RCT = randomized controlled trial; THC = delta-9-tetrahydrocannabinol.
a Refer to text and theNCI Dictionary of Cancer Termsfor additional information and definition of terms.
b Number of patients treated plus number of patient controls may not equal number of patients enrolled; number of patients enrolled equals number of patients initially recruited/considered by the researchers who conducted a study; number of patients treated equals number of enrolled patients who were given the treatment being studied AND for whom results were reported.
c Strongest evidence reported that the treatment under study has activity or otherwise improves the well-being of cancer patients.
d Concurrent therapy for symptoms treated (not cancer).
e For information about levels of evidence analysis and an explanation of the level of evidence scores, refer to Levels of Evidence for Human Studies of Integrative, Alternative, and Complementary Therapies.
[50] RCT Cancer-associated anorexia 469; dronabinol 152, megestrol acetate 159, or both 158; none Megestrol acetate provided increased appetite and weight gain, among advanced cancer patients compared with dronabinol alone No 1iC
[48] Pilot RCT Appetite 21; 11; 10 THC, compared with placebo, improved and enhanced taste and smell No 1iC
[53] RCT Cancer-related anorexia-cachexia syndrome 243;Cannabisextract 95, THC 100; 48 No differences in patients’ appetite or QoL were found No 1iC
[71] RCT Appetite 139; 72; 67 Increase in appetite No 1iC
[49] RCT Anorexia 47; 22; 25 Increased calorie intake No 1iC
[58] RCT Pain 10; 10; none Pain relief No 1iC
[60] RCT Pain 177; 60 (THC:CBD), 58 (THC); 59 THC:CBD extract group had reduced pain Yes, opioids 1iC
[61] RCT Pain 360; 269; 91 Decreased pain in low-dose group Yes, opioids 1iC
[62] Open-label extension Pain 43; 39 (THC:CBD), 4 (THC), none Decreased pain Yes, opioids 2C
[63] Observational study Pain 112; 47; 65 Decreased pain Yes, opioids,NSAIDs, gabapentin 2C

Current Clinical Trials

Use our advanced clinical trial search to find NCI-supported cancer clinical trials that are now enrolling patients. The search can be narrowed by location of the trial, type of treatment, name of the drug, and other criteria. General information about clinical trials is also available.

  1. Adams IB, Martin BR: Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (11): 1585-614, 1996.
  2. Agurell S, Halldin M, Lindgren JE, et al.: Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 38 (1): 21-43, 1986.
  3. Yamamoto I, Watanabe K, Narimatsu S, et al.: Recent advances in the metabolism of cannabinoids. Int J Biochem Cell Biol 27 (8): 741-6, 1995.
  4. Engels FK, de Jong FA, Sparreboom A, et al.: Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel. Oncologist 12 (3): 291-300, 2007.
  5. FDA Warns Companies Marketing Unproven Products, Derived From Marijuana, That Claim to Treat or Cure Cancer [News Release]. Silver Spring, Md: Food and Drug Administration, 2017. Available online. Last accessed January 4, 2019.
  6. Yamaori S, Okamoto Y, Yamamoto I, et al.: Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Drug Metab Dispos 39 (11): 2049-56, 2011.
  7. Jiang R, Yamaori S, Okamoto Y, et al.: Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19. Drug Metab Pharmacokinet 28 (4): 332-8, 2013.
  8. Berthiller J, Straif K, Boniol M, et al.: Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol 3 (12): 1398-403, 2008.
  9. Sidney S, Quesenberry CP, Friedman GD, et al.: Marijuana use and cancer incidence (California, United States). Cancer Causes Control 8 (5): 722-8, 1997.
  10. Hashibe M, Morgenstern H, Cui Y, et al.: Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 15 (10): 1829-34, 2006.
  11. Mehra R, Moore BA, Crothers K, et al.: The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med 166 (13): 1359-67, 2006.
  12. National Academies of Sciences, Engineering, and Medicine: The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press, 2017.
  13. Marks MA, Chaturvedi AK, Kelsey K, et al.: Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium. Cancer Epidemiol Biomarkers Prev 23 (1): 160-71, 2014.
  14. de Carvalho MF, Dourado MR, Fernandes IB, et al.: Head and neck cancer among marijuana users: a meta-analysis of matched case-control studies. Arch Oral Biol 60 (12): 1750-5, 2015.
  15. Daling JR, Doody DR, Sun X, et al.: Association of marijuana use and the incidence of testicular germ cell tumors. Cancer 115 (6): 1215-23, 2009.
  16. Trabert B, Sigurdson AJ, Sweeney AM, et al.: Marijuana use and testicular germ cell tumors. Cancer 117 (4): 848-53, 2011.
  17. Lacson JC, Carroll JD, Tuazon E, et al.: Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer 118 (21): 5374-83, 2012.
  18. Callaghan RC, Allebeck P, Akre O, et al.: Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011. Cancer Epidemiol Biomarkers Prev 26 (11): 1644-1652, 2017.
  19. Thomas AA, Wallner LP, Quinn VP, et al.: Association between cannabis use and the risk of bladder cancer: results from the California Men’s Health Study. Urology 85 (2): 388-92, 2015.
  20. Health Canada: Marihuana (Marijuana, Cannabis): Dried Plant for Administration by Ingestion or Other Means. Ottawa, Canada: Health Canada, 2010. Available online. Last accessed October 18, 2017.
  21. Pergam SA, Woodfield MC, Lee CM, et al.: Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer 123 (22): 4488-4497, 2017.
  22. Bar-Lev Schleider L, Mechoulam R, Lederman V, et al.: Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. Eur J Intern Med 49: 37-43, 2018.
  23. Anderson SP, Zylla DM, McGriff DM, et al.: Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota’s Medical Cannabis Program. J Oncol Pract 15 (4): e338-e345, 2019.
  24. Ofir R, Bar-Sela G, Weyl Ben-Arush M, et al.: Medical marijuana use for pediatric oncology patients: single institution experience. Pediatr Hematol Oncol 36 (5): 255-266, 2019.
  25. Guzmán M, Duarte MJ, Blázquez C, et al.: A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer 95 (2): 197-203, 2006.
  26. Velasco G, Sánchez C, Guzmán M: Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 12 (6): 436-44, 2012.
  27. Likar R, Koestenberger M, Stultschnig M, et al.: Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature. Anticancer Res 39 (10): 5797-5801, 2019.
  28. Yeshurun M, Shpilberg O, Herscovici C, et al.: Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study. Biol Blood Marrow Transplant 21 (10): 1770-5, 2015.
  29. Singh Y, Bali C: Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation. Case Rep Oncol 6 (3): 585-92, 2013.
  30. Foroughi M, Hendson G, Sargent MA, et al.: Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas–possible role of Cannabis inhalation. Childs Nerv Syst 27 (4): 671-9, 2011.
  31. Sutton IR, Daeninck P: Cannabinoids in the management of intractable chemotherapy-induced nausea and vomiting and cancer-related pain. J Support Oncol 4 (10): 531-5, 2006 Nov-Dec.
  32. Ahmedzai S, Carlyle DL, Calder IT, et al.: Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. Br J Cancer 48 (5): 657-63, 1983.
  33. Chan HS, Correia JA, MacLeod SM: Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial. Pediatrics 79 (6): 946-52, 1987.
  34. Johansson R, Kilkku P, Groenroos M: A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy. Cancer Treat Rev 9 (Suppl B): 25-33, 1982.
  35. Niiranen A, Mattson K: A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy. Am J Clin Oncol 8 (4): 336-40, 1985.
  36. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Antiemesis. Version 2.2017. Fort Washington, Pa: National Comprehensive Cancer Network, 2017. Available online with free registration. Last accessed November 14, 2017.
  37. Hesketh PJ, Kris MG, Basch E, et al.: Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 35 (28): 3240-3261, 2017.
  38. Tramèr MR, Carroll D, Campbell FA, et al.: Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323 (7303): 16-21, 2001.
  39. Ben Amar M: Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol 105 (1-2): 1-25, 2006.
  40. Smith LA, Azariah F, Lavender VT, et al.: Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev (11): CD009464, 2015.
  41. Meiri E, Jhangiani H, Vredenburgh JJ, et al.: Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Curr Med Res Opin 23 (3): 533-43, 2007.
  42. Chang AE, Shiling DJ, Stillman RC, et al.: A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy. Cancer 47 (7): 1746-51, 1981.
  43. Chang AE, Shiling DJ, Stillman RC, et al.: Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. Ann Intern Med 91 (6): 819-24, 1979.
  44. Levitt M, Faiman C, Hawks R, et al.: Randomized double blind comparison of delta-9-tetrahydrocannabinol and marijuana as chemotherapy antiemetics. [Abstract] Proceedings of the American Society of Clinical Oncology 3: A-C354, 91, 1984.
  45. Musty RE, Rossi R: Effects of smoked cannabis and oral delta-9-tetrahydrocannabinol on nausea and emesis after cancer chemotherapy: a review of state clinical trials. Journal of Cannabis Therapeutics 1 (1): 29-56, 2001. Also available online. Last accessed October 18, 2017.
  46. Duran M, Pérez E, Abanades S, et al.: Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol 70 (5): 656-63, 2010.
  47. Regelson W, Butler JR, Schulz J, et al.: Delta-9-tetrahydrocannabinol as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. In: Braude MC, Szara S: The Pharmacology of Marihuana. New York, NY: Raven Press, 1976, pp 763-76.
  48. Brisbois TD, de Kock IH, Watanabe SM, et al.: Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 22 (9): 2086-93, 2011.
  49. Turcott JG, Del Rocío Guillen Núñez M, Flores-Estrada D, et al.: The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial. Support Care Cancer 26 (9): 3029-3038, 2018.
  50. Jatoi A, Windschitl HE, Loprinzi CL, et al.: Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 20 (2): 567-73, 2002.
  51. Foltin RW, Brady JV, Fischman MW: Behavioral analysis of marijuana effects on food intake in humans. Pharmacol Biochem Behav 25 (3): 577-82, 1986.
  52. Foltin RW, Fischman MW, Byrne MF: Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite 11 (1): 1-14, 1988.
  53. Strasser F, Luftner D, Possinger K, et al.: Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol 24 (21): 3394-400, 2006.
  54. Aggarwal SK: Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results. Clin J Pain 29 (2): 162-71, 2013.
  55. Walker JM, Hohmann AG, Martin WJ, et al.: The neurobiology of cannabinoid analgesia. Life Sci 65 (6-7): 665-73, 1999.
  56. Calignano A, La Rana G, Giuffrida A, et al.: Control of pain initiation by endogenous cannabinoids. Nature 394 (6690): 277-81, 1998.
  57. Fields HL, Meng ID: Watching the pot boil. Nat Med 4 (9): 1008-9, 1998.
  58. Noyes R, Brunk SF, Baram DA, et al.: Analgesic effect of delta-9-tetrahydrocannabinol. J Clin Pharmacol 15 (2-3): 139-43, 1975 Feb-Mar.
  59. Noyes R, Brunk SF, Avery DA, et al.: The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther 18 (1): 84-9, 1975.
  60. Johnson JR, Burnell-Nugent M, Lossignol D, et al.: Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage 39 (2): 167-79, 2010.
  61. Portenoy RK, Ganae-Motan ED, Allende S, et al.: Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain 13 (5): 438-49, 2012.
  62. Johnson JR, Lossignol D, Burnell-Nugent M, et al.: An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage 46 (2): 207-18, 2013.
  63. Maida V, Ennis M, Irani S, et al.: Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring. J Support Oncol 6 (3): 119-24, 2008.
  64. Abrams DI, Couey P, Shade SB, et al.: Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther 90 (6): 844-51, 2011.
  65. Wilsey B, Marcotte T, Deutsch R, et al.: Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain 14 (2): 136-48, 2013.
  66. Wilsey B, Marcotte T, Tsodikov A, et al.: A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain 9 (6): 506-21, 2008.
  67. Andreae MH, Carter GM, Shaparin N, et al.: Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. J Pain 16 (12): 1221-1232, 2015.
  68. Lynch ME, Cesar-Rittenberg P, Hohmann AG: A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain. J Pain Symptom Manage 47 (1): 166-73, 2014.
  69. Noyes R, Baram DA: Cannabis analgesia. Compr Psychiatry 15 (6): 531-5, 1974 Nov-Dec.
  70. Zhang H, Xie M, Archibald SD, et al.: Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg 144 (11): 1017-1022, 2018.
  71. Beal JE, Olson R, Laubenstein L, et al.: Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 10 (2): 89-97, 1995.

Adverse Effects

Cannabisand Cannabinoids

Because cannabinoid receptors, unlike opioid receptors, are not located in the brainstem areas controlling respiration, lethal overdoses from Cannabis and cannabinoids do not occur.[1,2,3,4] However, cannabinoid receptors are present in other tissues throughout the body, not just in the central nervous system, and adverse effects include the following:

  • Tachycardia.
  • Hypotension.
  • Conjunctival injection.
  • Bronchodilation.
  • Muscle relaxation.
  • Decreased gastrointestinal motility.

Although cannabinoids are considered by some to be addictive drugs, their addictive potential is considerably lower than that of other prescribed agents or substances of abuse.[2,4] The brain develops a tolerance to cannabinoids.

Withdrawal symptoms such as irritability, insomnia with sleep electroencephalogram disturbance, restlessness, hot flashes, and, rarely, nausea and cramping have been observed. However, these symptoms appear to be mild compared with withdrawal symptoms associated with opiates or benzodiazepines, and the symptoms usually dissipate after a few days.

Unlike other commonly used drugs, cannabinoids are stored in adipose tissue and excreted at a low rate (half-life 1–3 days), so even abrupt cessation of cannabinoid intake is not associated with rapid declines in plasma concentrations that would precipitate severe or abrupt withdrawal symptoms or drug cravings.

Cannabidiol (CBD) is an inhibitor of cytochrome P450 isoforms in vitro. Because many anticancer therapies are metabolized by these enzymes, highly concentrated CBD oils used concurrently could potentially increase the toxicity or decrease the effectiveness of these therapies.[5,6]

Since Cannabis smoke contains many of the same components as tobacco smoke, there are valid concerns about the adverse pulmonary effects of inhaled Cannabis. A longitudinal study in a noncancer population evaluated repeated measurements of pulmonary function over 20 years in 5,115 men and women whose smoking histories were known.[7] While tobacco exposure was associated with decreased pulmonary function, the investigators concluded that occasional and low-cumulative Cannabis use was not associated with adverse effects on pulmonary function (forced expiratory volume in the first second of expiration [FEV1] and forced vital capacity [FVC]).

  1. Adams IB, Martin BR: Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (11): 1585-614, 1996.
  2. Grotenhermen F, Russo E, eds.: Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential. Binghamton, NY: The Haworth Press, 2002.
  3. Sutton IR, Daeninck P: Cannabinoids in the management of intractable chemotherapy-induced nausea and vomiting and cancer-related pain. J Support Oncol 4 (10): 531-5, 2006 Nov-Dec.
  4. Guzmán M: Cannabinoids: potential anticancer agents. Nat Rev Cancer 3 (10): 745-55, 2003.
  5. Yamaori S, Okamoto Y, Yamamoto I, et al.: Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Drug Metab Dispos 39 (11): 2049-56, 2011.
  6. Jiang R, Yamaori S, Okamoto Y, et al.: Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19. Drug Metab Pharmacokinet 28 (4): 332-8, 2013.
  7. Pletcher MJ, Vittinghoff E, Kalhan R, et al.: Association between marijuana exposure and pulmonary function over 20 years. JAMA 307 (2): 173-81, 2012.

Summary of the Evidence for Cannabis and Cannabinoids

To assist readers in evaluating the results of human studies of integrative, alternative, and complementary therapies for people with cancer, the strength of the evidence (i.e., the levels of evidence) associated with each type of treatment is provided whenever possible. To qualify for a level of evidence analysis, a study must:

  • Be published in a peer-reviewed scientific journal.
  • Report on therapeutic outcome or outcomes, such as tumor response, improvement in survival, or measured improvement in quality of life.
  • Describe clinical findings in sufficient detail for a meaningful evaluation to be made.

Separate levels of evidence scores are assigned to qualifying human studies on the basis of statistical strength of the study design and scientific strength of the treatment outcomes (i.e., endpoints) measured. The resulting two scores are then combined to produce an overall score. An overall level of evidence score cannot be assigned to cannabinoids because there has been insufficient clinical research. For an explanation of possible scores and additional information about levels of evidence analysis of Complementary and Alternative Medicine (CAM) treatments for people with cancer, refer to Levels of Evidence for Human Studies of Integrative, Alternative, and Complementary Therapies.

Cannabinoids

Several controlled clinical trials have been performed, and meta-analyses of these support a beneficial effect of cannabinoids (dronabinol and nabilone) on chemotherapy -induced nausea and vomiting (N/V) compared with placebo. Both dronabinol and nabilone are approved by the U.S. Food and Drug Administration for the prevention or treatment of chemotherapy-induced N/V in cancer patients but not for other symptom management.
  • There have been ten clinical trials on the use of inhaled Cannabis in cancer patients that can be divided into two groups. In one group, four small studies assessed antiemetic activity but each explored a different patient population and chemotherapy regimen. One study demonstrated no effect, the second study showed a positive effect versus placebo, the report of the third study did not provide enough information to characterize the overall outcome as positive or neutral. Consequently, there are insufficient data to provide an overall level of evidence assessment for the use of Cannabis for chemotherapy-induced N/V. Apparently, there are no published controlled clinical trials on the use of inhaled Cannabis for other cancer-related or cancer treatment–related symptoms.
  • An increasing number of trials are evaluating the oromucosal administration of Cannabis plant extract with fixed concentrations of cannabinoid components, with national drug regulatory agencies in Canada and in some European countries that issue approval for cancer pain.
  • At present, there is insufficient evidence to recommend inhaling Cannabis as a treatment for cancer-related symptoms or cancer treatment–related symptoms or cancer treatment-related side effects; however, additional research is needed.

Changes to This Summary (11 / 06 / 2020)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Editorial changes were made to this summary.

This summary is written and maintained by the PDQ Integrative, Alternative, and Complementary Therapies Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® – NCI’s Comprehensive Cancer Database pages.

About This PDQ Summary

Purpose of This Summary

This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the use of Cannabis and cannabinoids in the treatment of people with cancer. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions.

Reviewers and Updates

This summary is reviewed regularly and updated as necessary by the PDQ Integrative, Alternative, and Complementary Therapies Editorial Board, which is editorially independent of the National Cancer Institute (NCI). The summary reflects an independent review of the literature and does not represent a policy statement of NCI or the National Institutes of Health (NIH).

Board members review recently published articles each month to determine whether an article should:

  • be discussed at a meeting,
  • be cited with text, or
  • replace or update an existing article that is already cited.

Changes to the summaries are made through a consensus process in which Board members evaluate the strength of the evidence in the published articles and determine how the article should be included in the summary.

Any comments or questions about the summary content should be submitted to Cancer.gov through the NCI website’s Email Us. Do not contact the individual Board Members with questions or comments about the summaries. Board members will not respond to individual inquiries.

Levels of Evidence

Some of the reference citations in this summary are accompanied by a level-of-evidence designation. These designations are intended to help readers assess the strength of the evidence supporting the use of specific interventions or approaches. The PDQ Integrative, Alternative, and Complementary Therapies Editorial Board uses a formal evidence ranking system in developing its level-of-evidence designations.

Permission to Use This Summary

PDQ is a registered trademark. Although the content of PDQ documents can be used freely as text, it cannot be identified as an NCI PDQ cancer information summary unless it is presented in its entirety and is regularly updated. However, an author would be permitted to write a sentence such as “NCI’s PDQ cancer information summary about breast cancer prevention states the risks succinctly: [include excerpt from the summary].”

The preferred citation for this PDQ summary is:

PDQ® Integrative, Alternative, and Complementary Therapies Editorial Board. PDQ Cannabis and Cannabinoids. Bethesda, MD: National Cancer Institute. Updated <MM/DD/YYYY>. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq. Accessed <MM/DD/YYYY>. [PMID: 26389198]

Images in this summary are used with permission of the author(s), artist, and/or publisher for use within the PDQ summaries only. Permission to use images outside the context of PDQ information must be obtained from the owner(s) and cannot be granted by the National Cancer Institute. Information about using the illustrations in this summary, along with many other cancer-related images, is available in Visuals Online, a collection of over 2,000 scientific images.

See also  unbiased ratings reviews for cbd oil brands